APPLE INC, 10-Q filed on 7/31/2019
Quarterly Report
v3.19.2
Cover Page - shares
shares in Thousands
9 Months Ended
Jun. 29, 2019
Jul. 19, 2019
Entity Information [Line Items]    
Document Type 10-Q  
Document Quarterly Report true  
Document Period End Date Jun. 29, 2019  
Document Transition Report false  
Entity File Number 001-36743  
Entity Registrant Name Apple Inc  
Entity Incorporation, State or Country Code CA  
Entity Tax Identification Number 94-2404110  
Entity Address, Address Line One One Apple Park Way  
Entity Address, City or Town Cupertino  
Entity Address, State or Province CA  
Entity Address, Postal Zip Code 95014  
City Area Code 408  
Local Phone Number 996-1010  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Filer Category Large Accelerated Filer  
Entity Small Business false  
Entity Emerging Growth Company false  
Entity Shell Company false  
Entity Common Stock, Shares Outstanding (in shares)   4,519,180
Amendment Flag false  
Document Fiscal Year Focus 2019  
Document Fiscal Period Focus Q3  
Entity Central Index Key 0000320193  
Current Fiscal Year End Date --09-28  
Common Stock    
Entity Information [Line Items]    
Title of 12(b) Security Common Stock, $0.00001 par value per share  
Trading Symbol AAPL  
Security Exchange Name NASDAQ  
1.000% Notes due 2022    
Entity Information [Line Items]    
Title of 12(b) Security 1.000% Notes due 2022  
Trading Symbol  
Security Exchange Name NASDAQ  
1.375% Notes due 2024    
Entity Information [Line Items]    
Title of 12(b) Security 1.375% Notes due 2024  
Trading Symbol  
Security Exchange Name NASDAQ  
0.875% Notes due 2025    
Entity Information [Line Items]    
Title of 12(b) Security 0.875% Notes due 2025  
Trading Symbol  
Security Exchange Name NASDAQ  
1.625% Notes due 2026    
Entity Information [Line Items]    
Title of 12(b) Security 1.625% Notes due 2026  
Trading Symbol  
Security Exchange Name NASDAQ  
2.000% Notes due 2027    
Entity Information [Line Items]    
Title of 12(b) Security 2.000% Notes due 2027  
Trading Symbol  
Security Exchange Name NASDAQ  
1.375% Notes due 2029    
Entity Information [Line Items]    
Title of 12(b) Security 1.375% Notes due 2029  
Trading Symbol  
Security Exchange Name NASDAQ  
3.050% Notes due 2029    
Entity Information [Line Items]    
Title of 12(b) Security 3.050% Notes due 2029  
Trading Symbol  
Security Exchange Name NASDAQ  
3.600% Notes due 2042    
Entity Information [Line Items]    
Title of 12(b) Security 3.600% Notes due 2042  
Trading Symbol  
Security Exchange Name NASDAQ  
v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)
shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Net sales $ 53,809 $ 53,265 $ 196,134 $ 202,695
Cost of sales 33,582 32,844 122,055 124,940
Gross margin 20,227 20,421 74,079 77,755
Operating expenses:        
Research and development 4,257 3,701 12,107 10,486
Selling, general and administrative 4,426 4,108 13,667 12,489
Total operating expenses 8,683 7,809 25,774 22,975
Operating income 11,544 12,612 48,305 54,780
Other income/(expense), net 367 672 1,305 1,702
Income before provision for income taxes 11,911 13,284 49,610 56,482
Provision for income taxes 1,867 1,765 8,040 11,076
Net income $ 10,044 $ 11,519 $ 41,570 $ 45,406
Earnings per share:        
Basic (in dollars per share) $ 2.20 $ 2.36 $ 8.92 $ 9.07
Diluted (in dollars per share) $ 2.18 $ 2.34 $ 8.86 $ 8.99
Shares used in computing earnings per share:        
Basic (in shares) 4,570,633 4,882,167 4,660,175 5,006,640
Diluted (in shares) 4,601,380 4,926,609 4,691,759 5,050,963
Products        
Net sales $ 42,354 $ 43,095 $ 162,354 $ 173,546
Cost of sales 29,473 28,956 109,758 113,467
Services        
Net sales 11,455 10,170 33,780 29,149
Cost of sales $ 4,109 $ 3,888 $ 12,297 $ 11,473
v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Statement of Comprehensive Income [Abstract]        
Net income $ 10,044 $ 11,519 $ 41,570 $ 45,406
Other comprehensive income/(loss):        
Change in foreign currency translation, net of tax (219) (590) (123) (287)
Change in unrealized gains/losses on derivative instruments, net of tax:        
Change in fair value of derivatives (108) 109 (492) 170
Adjustment for net (gains)/losses realized and included in net income (44) 978 (107) 873
Total change in unrealized gains/losses on derivative instruments (152) 1,087 (599) 1,043
Change in unrealized gains/losses on marketable securities, net of tax:        
Change in fair value of marketable securities 1,253 (568) 3,405 (3,417)
Adjustment for net (gains)/losses realized and included in net income (22) 24 43 (22)
Total change in unrealized gains/losses on marketable securities 1,231 (544) 3,448 (3,439)
Total other comprehensive income/(loss) 860 (47) 2,726 (2,683)
Total comprehensive income $ 10,904 $ 11,472 $ 44,296 $ 42,723
v3.19.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)
$ in Millions
Jun. 29, 2019
Sep. 29, 2018
Current assets:    
Cash and cash equivalents $ 50,530 $ 25,913
Marketable securities 44,084 40,388
Accounts receivable, net 14,148 23,186
Inventories 3,355 3,956
Vendor non-trade receivables 12,326 25,809
Other current assets 10,530 12,087
Total current assets 134,973 131,339
Non-current assets:    
Marketable securities 115,996 170,799
Property, plant and equipment, net 37,636 41,304
Other non-current assets 33,634 22,283
Total non-current assets 187,266 234,386
Total assets 322,239 365,725
Current liabilities:    
Accounts payable 29,115 55,888
Other current liabilities 31,673 33,327
Deferred revenue 5,434 5,966
Commercial paper 9,953 11,964
Term debt 13,529 8,784
Total current liabilities 89,704 115,929
Non-current liabilities:    
Term debt 84,936 93,735
Other non-current liabilities 51,143 48,914
Total non-current liabilities 136,079 142,649
Total liabilities 225,783 258,578
Commitments and contingencies
Shareholders’ equity:    
Common stock and additional paid-in capital, $0.00001 par value: 12,600,000 shares authorized; 4,531,395 and 4,754,986 shares issued and outstanding, respectively 43,371 40,201
Retained earnings 53,724 70,400
Accumulated other comprehensive income/(loss) (639) (3,454)
Total shareholders’ equity 96,456 107,147
Total liabilities and shareholders’ equity $ 322,239 $ 365,725
v3.19.2
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares
Jun. 29, 2019
Sep. 29, 2018
Statement of Financial Position [Abstract]    
Common stock, par value (in dollars per share) $ 0.00001 $ 0.00001
Common stock, shares authorized (in shares) 12,600,000,000 12,600,000,000
Common stock, shares issued (in shares) 4,531,395,000 4,754,986,000
Common stock, shares outstanding (in shares) 4,531,395,000 4,754,986,000
v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY (Unaudited) - USD ($)
$ in Millions
Total
Common stock and additional paid-in capital
Retained earnings
Accumulated other comprehensive income/(loss)
Beginning balances at Sep. 30, 2017 $ 134,047 $ 35,867 $ 98,330 $ (150)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued   328    
Common stock withheld related to net share settlement of equity awards   (1,642) (807)  
Share-based compensation   4,071    
Net income 45,406   45,406  
Dividends and dividend equivalents declared     (10,162)  
Common stock repurchased     (53,609)  
Other comprehensive income/(loss) (2,683)     (2,683)
Ending balances at Jun. 30, 2018 $ 114,949 38,624 79,436 (3,111)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 1.99      
Beginning balances at Mar. 31, 2018 $ 126,878 38,044 91,898 (3,064)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued   1    
Common stock withheld related to net share settlement of equity awards   (797) (358)  
Share-based compensation   1,376    
Net income 11,519   11,519  
Dividends and dividend equivalents declared     (3,623)  
Common stock repurchased     (20,000)  
Other comprehensive income/(loss) (47)     (47)
Ending balances at Jun. 30, 2018 $ 114,949 38,624 79,436 (3,111)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.73      
Beginning balances at Sep. 29, 2018 $ 107,147 40,201 70,400 (3,454)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued   391    
Common stock withheld related to net share settlement of equity awards   (1,885) (944)  
Share-based compensation   4,664    
Net income 41,570   41,570  
Dividends and dividend equivalents declared     (10,605)  
Common stock repurchased (49,200)   (49,198)  
Other comprehensive income/(loss) 2,726     2,726
Ending balances at Jun. 29, 2019 $ 96,456 43,371 53,724 (639)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 2.23      
Beginning balances at Mar. 30, 2019 $ 105,860 42,801 64,558 (1,499)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Common stock issued   1    
Common stock withheld related to net share settlement of equity awards   (958) (336)  
Share-based compensation   1,527    
Net income 10,044   10,044  
Dividends and dividend equivalents declared     (3,580)  
Common stock repurchased     (16,962)  
Other comprehensive income/(loss) 860     860
Ending balances at Jun. 29, 2019 $ 96,456 $ 43,371 $ 53,724 $ (639)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Dividends and dividend equivalents declared per share or RSU (in dollars per share or RSU) $ 0.77      
v3.19.2
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)
$ in Millions
9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Statement of Cash Flows [Abstract]    
Cash, cash equivalents and restricted cash, beginning balances $ 25,913 $ 20,289
Operating activities:    
Net income 41,570 45,406
Adjustments to reconcile net income to cash generated by operating activities:    
Depreciation and amortization 9,368 8,149
Share-based compensation expense 4,569 3,995
Deferred income tax benefit (38) (33,109)
Other (340) (410)
Changes in operating assets and liabilities:    
Accounts receivable, net 9,013 3,756
Inventories 496 (1,114)
Vendor non-trade receivables 13,483 5,536
Other current and non-current assets 693 (65)
Accounts payable (19,804) (10,410)
Deferred revenue (776) (73)
Other current and non-current liabilities (8,753) 36,250
Cash generated by operating activities 49,481 57,911
Investing activities:    
Purchases of marketable securities (21,902) (56,133)
Proceeds from maturities of marketable securities 26,783 46,290
Proceeds from sales of marketable securities 49,516 41,614
Payments for acquisition of property, plant and equipment (7,718) (10,272)
Payments made in connection with business acquisitions, net (611) (431)
Purchases of non-marketable securities (632) (1,788)
Proceeds from non-marketable securities 1,526 310
Other (268) (523)
Cash generated by investing activities 46,694 19,067
Financing activities:    
Proceeds from issuance of common stock 391 328
Payments for taxes related to net share settlement of equity awards (2,626) (2,267)
Payments for dividends and dividend equivalents (10,640) (10,182)
Repurchases of common stock (49,453) (53,634)
Proceeds from issuance of term debt, net 0 6,969
Repayments of term debt (5,500) (6,500)
Repayments of commercial paper, net (2,026) (10)
Other (83) 0
Cash used in financing activities (69,937) (65,296)
Increase in cash, cash equivalents and restricted cash 26,238 11,682
Cash, cash equivalents and restricted cash, ending balances 52,151 31,971
Supplemental cash flow disclosure:    
Cash paid for income taxes, net 11,795 8,819
Cash paid for interest $ 2,563 $ 2,120
v3.19.2
Summary of Significant Accounting Policies
9 Months Ended
Jun. 29, 2019
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies Summary of Significant Accounting Policies
Basis of Presentation and Preparation
The accompanying condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 29, 2018 (the “2018 Form 10-K”).
The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. A 14th week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters. The Company’s fiscal years 2019 and 2018 span 52 weeks each. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
Recently Adopted Accounting Pronouncements
Revenue Recognition
In the first quarter of 2019, the Company adopted the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”), and additional ASUs issued to clarify the guidance in ASU 2014-09 (collectively the “new revenue standard”), which amends the existing accounting standards for revenue recognition. The Company adopted the new revenue standard utilizing the full retrospective transition method. The Company did not restate total net sales in the prior periods presented, as adoption of the new revenue standard did not have a material impact on previously reported amounts.
Additionally, beginning in the first quarter of 2019, the Company classified the amortization of the deferred value of Maps, Siri® and free iCloud® services, which are bundled in the sales price of iPhone®, Mac®, iPad® and certain other products, in services net sales. Historically, the Company classified the amortization of these amounts in products net sales consistent with its management reporting framework. As a result, products and services net sales information for the third quarter and first nine months of 2018 was reclassified to conform to the 2019 presentation.
Financial Instruments
In the first quarter of 2019, the Company adopted FASB ASU No. 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”), which updates certain aspects of the recognition, measurement, presentation and disclosure of financial instruments. The adoption of ASU 2016-01 did not have a material impact on the Company’s condensed consolidated financial statements.
Income Taxes
In the first quarter of 2019, the Company adopted FASB ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory (“ASU 2016-16”), which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. The Company adopted ASU 2016-16 utilizing the modified retrospective transition method. Upon adoption, the Company recorded $2.7 billion of net deferred tax assets, reduced other non-current assets by $128 million, and increased retained earnings by $2.6 billion on its Condensed Consolidated Balance Sheet. The Company will recognize incremental deferred income tax expense as these net deferred tax assets are utilized.
Restricted Cash
In the first quarter of 2019, the Company adopted FASB ASU No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”), which enhances and clarifies the guidance on the classification and presentation of restricted cash in the statement of cash flows and requires additional disclosures about restricted cash balances.
Earnings Per Share
The following table shows the computation of basic and diluted earnings per share for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (net income in millions and shares in thousands):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Numerator:
 
 
 
 
 
 
 
Net income
$
10,044

 
$
11,519

 
$
41,570

 
$
45,406

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted-average basic shares outstanding
4,570,633

 
4,882,167

 
4,660,175

 
5,006,640

Effect of dilutive securities
30,747

 
44,442

 
31,584

 
44,323

Weighted-average diluted shares
4,601,380

 
4,926,609

 
4,691,759

 
5,050,963

 
 
 
 
 
 
 
 
Basic earnings per share
$
2.20

 
$
2.36

 
$
8.92

 
$
9.07

Diluted earnings per share
$
2.18

 
$
2.34

 
$
8.86

 
$
8.99


Potentially dilutive securities representing 1.5 million and 20.5 million shares of common stock were excluded from the computation of diluted earnings per share for the three- and nine-month periods ended June 29, 2019, respectively, because their effect would have been antidilutive.
Restricted Cash and Restricted Marketable Securities
The Company considers cash and marketable securities to be restricted when withdrawal or general use is legally restricted. The Company records restricted cash as other assets in the Condensed Consolidated Balance Sheets, and determines current or non-current classification based on the expected duration of the restriction. The Company records restricted marketable securities as current or non-current marketable securities in the Condensed Consolidated Balance Sheets based on the classification of the underlying securities.
v3.19.2
Revenue Recognition
9 Months Ended
Jun. 29, 2019
Revenue from Contract with Customer [Abstract]  
Revenue Recognition Revenue Recognition
Net sales consist of revenue from the sale of iPhone, Mac, iPad, services and other products. The Company recognizes revenue at the amount to which it expects to be entitled when control of the products or services is transferred to its customers. Control is generally transferred when the Company has a present right to payment and title and the significant risks and rewards of ownership of products or services are transferred to its customers. For most of the Company’s products net sales, control transfers when products are shipped. For the Company’s services net sales, control transfers over time as services are delivered. Payment for products and services net sales is collected within a short period of time following transfer of control or commencement of delivery of services, as applicable.
The Company records reductions to products net sales related to future product returns, price protection and other customer incentive programs based on the Company’s expectations and historical experience.
For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct, the Company allocates revenue to all distinct performance obligations based on their relative stand-alone selling prices (“SSP”). When available, the Company uses observable prices to determine the SSP. When observable prices are not available, SSPs are established that reflect the Company’s best estimates of what the selling prices of the performance obligations would be if they were sold regularly on a stand-alone basis. The Company’s process for estimating SSPs without observable prices considers multiple factors that may vary depending upon the unique facts and circumstances related to each performance obligation including, where applicable, prices charged by the Company for similar offerings, market trends in the pricing for similar offerings, product-specific business objectives and the estimated cost to provide the performance obligation.
The Company has identified up to three performance obligations regularly included in arrangements involving the sale of iPhone, Mac, iPad and certain other products. The first performance obligation, which represents the substantial portion of the allocated sales price, is the hardware and bundled software delivered at the time of sale. The second performance obligation is the right to receive certain product-related bundled services, which include iCloud, Siri and Maps. The third performance obligation is the right to receive, on a when-and-if-available basis, future unspecified software upgrades relating to the software bundled with each device. The Company allocates revenue and any related discounts to these performance obligations based on their relative SSPs. Because the Company lacks observable prices for the undelivered performance obligations, the allocation of revenue is based on the Company’s estimated SSPs. Revenue allocated to the delivered hardware and bundled software is recognized when control has transferred to the customer, which generally occurs when the product is shipped. Revenue allocated to the product-related bundled services and unspecified software upgrade rights is deferred and recognized on a straight-line basis over the estimated period they are expected to be provided. Cost of sales related to delivered hardware and bundled software, including estimated warranty costs, are recognized at the time of sale. Costs incurred to provide product-related bundled services and unspecified software upgrade rights are recognized as cost of sales as incurred.
For certain long-term service arrangements, the Company has performance obligations for services it has not yet delivered. For these arrangements, the Company does not have a right to bill for the undelivered services. The Company has determined that any unbilled consideration relates entirely to the value of the undelivered services. Accordingly, the Company has not recognized revenue, and has elected not to disclose amounts, related to these undelivered services.
For the sale of third-party products where the Company obtains control of the product before transferring it to the customer, the Company recognizes revenue based on the gross amount billed to customers. The Company considers multiple factors when determining whether it obtains control of third-party products including, but not limited to, evaluating if it has the ability to establish the price of the product, retains inventory risk for tangible products or has the responsibility for ensuring acceptability of the product. For third-party applications sold through the App Store®, Mac App Store and TV App Store and certain digital content sold through the iTunes Store®, the Company does not obtain control of the product before transferring it to the customer. Therefore, the Company accounts for such sales on a net basis by recognizing in services net sales only the commission it retains.
The Company has elected to record revenue net of taxes collected from customers that are remitted to governmental authorities, with the collected taxes recorded within other current liabilities until remitted to the relevant government authority.
Deferred Revenue
As of June 29, 2019 and September 29, 2018, the Company had total deferred revenue of $8.0 billion and $8.8 billion, respectively. As of June 29, 2019, the Company expects 68% of total deferred revenue to be realized in less than a year, 25% within one-to-two years, 6% within two-to-three years and 1% in greater than three years.
Disaggregated Revenue
Net sales disaggregated by significant products and services for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 were as follows (in millions):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
iPhone (1)
$
25,986

 
$
29,470

 
$
109,019

 
$
128,133

Mac (1)
5,820

 
5,258

 
18,749

 
17,858

iPad (1)
5,023

 
4,634

 
16,624

 
14,397

Wearables, Home and Accessories (1)(2)
5,525

 
3,733

 
17,962

 
13,158

Services (3)
11,455

 
10,170

 
33,780

 
29,149

Total net sales (4)
$
53,809

 
$
53,265

 
$
196,134

 
$
202,695

(1)
Products net sales include amortization of the deferred value of unspecified software upgrade rights, which are bundled in the sales price of the respective product.
(2)
Wearables, Home and Accessories net sales include sales of AirPods®, Apple TV®, Apple Watch®, Beats® products, HomePod™, iPod touch® and Apple-branded and third-party accessories.
(3)
Services net sales include sales from the Company’s digital content stores and streaming services, AppleCare®, Apple Pay®, licensing and other services. Services net sales also include amortization of the deferred value of Maps, Siri and free iCloud services, which are bundled in the sales price of certain products.
(4)
Includes $2.0 billion of revenue recognized in the three months ended June 29, 2019 that was included in deferred revenue as of March 30, 2019, $2.0 billion of revenue recognized in the three months ended June 30, 2018 that was included in deferred revenue as of March 31, 2018, $4.9 billion of revenue recognized in the nine months ended June 29, 2019 that was included in deferred revenue as of September 29, 2018, and $4.7 billion of revenue recognized in the nine months ended June 30, 2018 that was included in deferred revenue as of September 30, 2017.
The Company’s proportion of net sales by disaggregated revenue source was generally consistent for each reportable segment in Note 11, “Segment Information and Geographic Data” for the three- and nine-month periods ended June 29, 2019 and June 30, 2018.
v3.19.2
Financial Instruments
9 Months Ended
Jun. 29, 2019
Investments, All Other Investments [Abstract]  
Financial Instruments Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The Company’s investments in marketable debt securities have been classified and accounted for as available-for-sale. The Company classifies its marketable debt securities as either short-term or long-term based on each instrument’s underlying contractual maturity date. Unrealized gains and losses on marketable debt securities classified as available-for-sale are recognized in other comprehensive income/(loss) (“OCI”).
The Company’s investments in marketable equity securities are classified based on the nature of the securities and their availability for use in current operations. The Company’s marketable equity securities are measured at fair value with gains and losses recognized in other income/(expense), net.
The following tables show the Company’s cash and marketable securities by significant investment category as of June 29, 2019 and September 29, 2018 (in millions):
 
June 29, 2019
 
Adjusted
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair
Value
 
Cash and
Cash
Equivalents
 
Short-Term
Marketable
Securities
 
Long-Term
Marketable
Securities
Cash
$
12,075

 
$

 
$

 
$
12,075

 
$
12,075

 
$

 
$

Level 1 (1):
 
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds
10,558

 

 

 
10,558

 
10,558

 

 

Subtotal
10,558

 

 

 
10,558

 
10,558

 

 

Level 2 (2):
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Treasury securities
37,307

 
22

 
(102
)
 
37,227

 
11,116

 
8,436

 
17,675

U.S. agency securities
9,552

 
1

 
(5
)
 
9,548

 
7,711

 
450

 
1,387

Non-U.S. government securities
20,569

 
272

 
(63
)
 
20,778

 
636

 
3,467

 
16,675

Certificates of deposit and time deposits
4,838

 

 

 
4,838

 
3,495

 
1,273

 
70

Commercial paper
5,161

 

 

 
5,161

 
4,930

 
231

 

Corporate debt securities
93,896

 
550

 
(173
)
 
94,273

 
9

 
29,027

 
65,237

Municipal securities
961

 
9

 
(1
)
 
969

 

 
65

 
904

Mortgage- and asset-backed securities
15,262

 
38

 
(117
)
 
15,183

 

 
1,135

 
14,048

Subtotal
187,546

 
892

 
(461
)
 
187,977

 
27,897

 
44,084

 
115,996

Total (3)
$
210,179

 
$
892

 
$
(461
)
 
$
210,610

 
$
50,530

 
$
44,084

 
$
115,996

 
September 29, 2018
 
Adjusted
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair
Value
 
Cash and
Cash
Equivalents
 
Short-Term
Marketable
Securities
 
Long-Term
Marketable
Securities
Cash
$
11,575

 
$

 
$

 
$
11,575

 
$
11,575

 
$

 
$

Level 1 (1):
 
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds
8,083

 

 

 
8,083

 
8,083

 

 

Mutual funds
799

 

 
(116
)
 
683

 

 
683

 

Subtotal
8,882

 

 
(116
)
 
8,766

 
8,083

 
683

 

Level 2 (2):
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Treasury securities
47,296

 

 
(1,202
)
 
46,094

 
1,613

 
7,606

 
36,875

U.S. agency securities
4,127

 

 
(48
)
 
4,079

 
1,732

 
360

 
1,987

Non-U.S. government securities
21,601

 
49

 
(250
)
 
21,400

 

 
3,355

 
18,045

Certificates of deposit and time deposits
3,074

 

 

 
3,074

 
1,247

 
1,330

 
497

Commercial paper
2,573

 

 

 
2,573

 
1,663

 
910

 

Corporate debt securities
123,001

 
152

 
(2,038
)
 
121,115

 

 
25,162

 
95,953

Municipal securities
946

 

 
(12
)
 
934

 

 
178

 
756

Mortgage- and asset-backed securities
18,105

 
8

 
(623
)
 
17,490

 

 
804

 
16,686

Subtotal
220,723

 
209

 
(4,173
)
 
216,759

 
6,255

 
39,705

 
170,799

Total (3)
$
241,180

 
$
209

 
$
(4,289
)
 
$
237,100

 
$
25,913

 
$
40,388

 
$
170,799

(1)
Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities.
(2)
Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
(3)
As of June 29, 2019 and September 29, 2018, total cash, cash equivalents and marketable securities included $19.5 billion and $20.3 billion, respectively, that was restricted from general use, related to the State Aid Decision (refer to Note 5, “Income Taxes”) and other agreements.
The Company may sell certain of its marketable debt securities prior to their stated maturities for reasons including, but not limited to, managing liquidity, credit risk, duration and asset allocation. The maturities of the Company’s long-term marketable debt securities generally range from one to five years.
The following tables show information about the Company’s marketable securities that had been in a continuous unrealized loss position for less than 12 months and for 12 months or greater as of June 29, 2019 and September 29, 2018 (in millions):
 
June 29, 2019
 
Continuous Unrealized Losses
 
Less than 12 Months
 
12 Months or Greater
 
Total
Fair value of marketable debt securities
$
11,853

 
$
71,984

 
$
83,837

Unrealized losses
$
(44
)
 
$
(417
)
 
$
(461
)
 
September 29, 2018
 
Continuous Unrealized Losses
 
Less than 12 Months
 
12 Months or Greater
 
Total
Fair value of marketable securities
$
126,238

 
$
60,599

 
$
186,837

Unrealized losses
$
(2,400
)
 
$
(1,889
)
 
$
(4,289
)

The Company typically invests in highly rated securities, with the primary objective of minimizing the potential risk of principal loss. The Company’s investment policy generally requires securities to be investment grade and limits the amount of credit exposure to any one issuer. Fair values were determined for each individual security in the investment portfolio. When evaluating a marketable debt security for other-than-temporary impairment, the Company reviews factors such as the length of time and extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, changes in market interest rates and the Company’s intent to sell, or whether it is more likely than not it will be required to sell the security before recovery of the security’s cost basis. As of June 29, 2019, the Company does not consider any of its marketable debt securities to be other-than-temporarily impaired.
Non-Marketable Securities
The Company holds non-marketable equity securities of certain privately held companies without readily determinable fair values, and has elected to apply the measurement alternative. As such, the Company’s non-marketable equity securities are measured at cost, less any impairment, and are adjusted for changes in fair value resulting from observable transactions for identical or similar investments of the same issuer. Gains and losses on non-marketable equity securities are recognized in other income/(expense), net. As of June 29, 2019, the Company’s non-marketable equity securities had a carrying value of $2.4 billion.
Restricted Cash
A reconciliation of the Company’s cash and cash equivalents in the Condensed Consolidated Balance Sheet to cash, cash equivalents and restricted cash in the Condensed Consolidated Statement of Cash Flows as of June 29, 2019 is as follows (in millions):
 
June 29,
2019
Cash and cash equivalents
$
50,530

Restricted cash included in other current assets
266

Restricted cash included in other non-current assets
1,355

Cash, cash equivalents and restricted cash
$
52,151


The Company’s restricted cash primarily consisted of cash required to be on deposit under a contractual agreement with a bank to support the Company’s iPhone Upgrade Program.
Derivative Financial Instruments
The Company may use derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, net investments in certain foreign subsidiaries, and certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations or the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates.
To protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.
To protect the net investment in a foreign operation from fluctuations in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset a portion of the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. In addition, the Company may use non-derivative financial instruments, such as its foreign currency–denominated debt, as hedges of its net investments in certain foreign subsidiaries. In both of these cases, the Company designates these instruments as net investment hedges.
To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in foreign currency exchange rates, the Company may enter into forward contracts, cross-currency swaps or other instruments. These instruments may offset a portion of the foreign currency remeasurement gains or losses, or changes in fair value. The Company may designate these instruments as either cash flow or fair value hedges. As of June 29, 2019, the Company’s hedged term debt– and marketable securities–related foreign currency transactions are expected to be recognized within 23 years.
The Company may also enter into non-designated foreign currency contracts to offset a portion of the foreign currency exchange gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies.
To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in interest rates, the Company may enter into interest rate swaps, options or other instruments. These instruments may offset a portion of the changes in interest income or expense, or changes in fair value. The Company designates these instruments as either cash flow or fair value hedges. As of June 29, 2019, the Company’s hedged interest rate transactions are expected to be recognized within 8 years.
Cash Flow Hedges
The effective portions of cash flow hedges are recorded in accumulated other comprehensive income/(loss) (“AOCI”) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. For options designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness. The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net.
Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified into other income/(expense), net in the period of de-designation. Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other transactions.
Net Investment Hedges
The effective portions of net investment hedges are recorded in OCI as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net. For foreign exchange forward contracts designated as net investment hedges, the Company excludes changes in fair value relating to changes in the forward carry component from its assessment of hedge effectiveness. Accordingly, any gains or losses related to this forward carry component are recognized in earnings in the current period.
Fair Value Hedges
Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item in the same line in the Condensed Consolidated Statements of Operations. For foreign exchange forward contracts designated as fair value hedges, the Company excludes changes in fair value relating to changes in the forward carry component from its assessment of hedge effectiveness. Amounts excluded from the effectiveness testing of fair value hedges were gains of $171 million and $645 million for the three- and nine-month periods ended June 29, 2019, respectively, and were recognized in other income/(expense), net.
Non-Designated Derivatives
Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates. As a result, during the three- and nine-month periods ended June 29, 2019, respectively, the Company recognized gains of $58 million and $283 million in net sales, gains of $40 million and $108 million in cost of sales and losses of $34 million and $58 million in other income/(expense), net. During the three- and nine-month periods ended June 30, 2018, respectively, the Company recognized a gain of $135 million and a loss of $7 million in net sales, a gain of $151 million and a loss of $61 million in cost of sales and a gain of $132 million and a loss of $241 million in other income/(expense), net.
The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company’s accounting treatment for these derivative instruments is based on its hedge designation. The following tables show the Company’s derivative instruments at gross fair value as of June 29, 2019 and September 29, 2018 (in millions):
 
June 29, 2019
 
Fair Value of
Derivatives Designated
as Hedge Instruments
 
Fair Value of
Derivatives Not Designated
as Hedge Instruments
 
Total
Fair Value
Derivative assets (1):
 
 
 
 
 
Foreign exchange contracts
$
1,179

 
$
184

 
$
1,363

Interest rate contracts
$
449

 
$

 
$
449

 
 
 
 
 
 
Derivative liabilities (2):
 
 
 
 
 
Foreign exchange contracts
$
860

 
$
251

 
$
1,111

Interest rate contracts
$
112

 
$

 
$
112

 
September 29, 2018
 
Fair Value of
Derivatives Designated
as Hedge Instruments
 
Fair Value of
Derivatives Not Designated
as Hedge Instruments
 
Total
Fair Value
Derivative assets (1):
 
 
 
 
 
Foreign exchange contracts
$
1,015

 
$
259

 
$
1,274

 
 
 
 
 
 
Derivative liabilities (2):
 
 
 
 
 
Foreign exchange contracts
$
543

 
$
137

 
$
680

Interest rate contracts
$
1,456

 
$

 
$
1,456

(1)
The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets and other non-current assets in the Condensed Consolidated Balance Sheets.
(2)
The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as other current liabilities and other non-current liabilities in the Condensed Consolidated Balance Sheets.
The Company classifies cash flows related to derivative financial instruments as operating activities in its Condensed Consolidated Statements of Cash Flows.
The following table shows the pre-tax gains and losses of the Company’s derivative and non-derivative instruments designated as cash flow, net investment and fair value hedges in OCI and the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (in millions):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Gains/(Losses) recognized in OCI – effective portion:
 
 
 
 
 
 
 
Cash flow hedges:
 
 
 
 
 
 
 
Foreign exchange contracts
$
(147
)
 
$
40

 
$
(689
)
 
$
230

Interest rate contracts

 

 

 
1

Total
$
(147
)
 
$
40

 
$
(689
)
 
$
231

 
 
 
 
 
 
 
 
Net investment hedges:
 
 
 
 
 
 
 
Foreign currency debt
$
(32
)
 
$
13

 
$
(55
)
 
$
(18
)
 
 
 
 
 
 
 
 
Gains/(Losses) reclassified from AOCI into net income – effective portion:
 
 
 
 
 
 
 
Cash flow hedges:
 
 
 
 
 
 
 
Foreign exchange contracts
$
53

 
$
(1,231
)
 
$
69

 
$
(1,068
)
Interest rate contracts
(2
)
 

 
(5
)
 
3

Total
$
51

 
$
(1,231
)
 
$
64

 
$
(1,065
)
 
 
 
 
 
 
 
 
Gains/(Losses) on derivative instruments:
 
 
 
 
 
 
 
Fair value hedges:
 
 
 
 
 
 
 
Foreign exchange contracts
$
(136
)
 
$
31

 
$
509

 
$
31

Interest rate contracts
671

 
(230
)
 
1,793

 
(1,178
)
Total
$
535

 
$
(199
)
 
$
2,302

 
$
(1,147
)
 
 
 
 
 
 
 
 
Gains/(Losses) related to hedged items:
 
 
 
 
 
 
 
Fair value hedges:
 
 
 
 
 
 
 
Marketable securities
$
136

 
$
(31
)
 
$
(508
)
 
$
(31
)
Fixed-rate debt
(671
)
 
230

 
(1,793
)
 
1,178

Total
$
(535
)
 
$
199

 
$
(2,301
)
 
$
1,147


The following table shows the notional amounts of the Company’s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of June 29, 2019 and September 29, 2018 (in millions):
 
June 29, 2019
 
September 29, 2018
 
Notional
Amount
 
Credit Risk
Amount
 
Notional
Amount
 
Credit Risk
Amount
Instruments designated as accounting hedges:
 
 
 
 
 
 
 
Foreign exchange contracts
$
55,067

 
$
1,179

 
$
65,368

 
$
1,015

Interest rate contracts
$
31,250

 
$
449

 
$
33,250

 
$

 
 
 
 
 
 
 
 
Instruments not designated as accounting hedges:
 
 
 
 
 
 
 
Foreign exchange contracts
$
54,744

 
$
184

 
$
63,062

 
$
259


The notional amounts for outstanding derivative instruments provide one measure of the transaction volume outstanding and do not represent the amount of the Company’s exposure to credit or market loss. The credit risk amounts represent the Company’s gross exposure to potential accounting loss on derivative instruments that are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency or interest rates at each respective date. The Company’s exposure to credit loss and market risk will vary over time as currency and interest rates change. Although the table above reflects the notional and credit risk amounts of the Company’s derivative instruments, it does not reflect the gains or losses associated with the exposures and transactions that the instruments are intended to hedge. The amounts ultimately realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.
The Company generally enters into master netting arrangements, which are designed to reduce credit risk by permitting net settlement of transactions with the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values in its Condensed Consolidated Balance Sheets. As of June 29, 2019, the net cash collateral received by the Company related to derivative instruments under its collateral security arrangements was $603 million, which was recorded as other current liabilities in the Condensed Consolidated Balance Sheet. As of September 29, 2018, the net cash collateral posted by the Company related to derivative instruments under its collateral security arrangements was $1.0 billion, which was recorded as other current assets in the Condensed Consolidated Balance Sheet.
Under master netting arrangements with the respective counterparties to the Company’s derivative contracts, the Company is allowed to net settle transactions with a single net amount payable by one party to the other. As of June 29, 2019 and September 29, 2018, the potential effects of these rights of set-off associated with the Company’s derivative contracts, including the effects of collateral, would be a reduction to both derivative assets and derivative liabilities of $1.8 billion and $2.1 billion, respectively, resulting in a net derivative liability of $14 million and a net derivative asset of $138 million, respectively.
Accounts Receivable
Trade Receivables
The Company has considerable trade receivables outstanding with its third-party cellular network carriers, wholesalers, retailers, resellers, small and mid-sized businesses and education, enterprise and government customers. The Company generally does not require collateral from its customers; however, the Company will require collateral or third-party credit support in certain instances to limit credit risk. In addition, when possible, the Company attempts to limit credit risk on trade receivables with credit insurance for certain customers or by requiring third-party financing, loans or leases to support credit exposure. These credit-financing arrangements are directly between the third-party financing company and the end customer. As such, the Company generally does not assume any recourse or credit risk sharing related to any of these arrangements.
As of June 29, 2019, the Company had one customer that represented 10% or more of total trade receivables, which accounted for 11%. As of September 29, 2018, the Company had one customer that represented 10% or more of total trade receivables, which accounted for 10%. The Company’s cellular network carriers accounted for 42% and 59% of total trade receivables as of June 29, 2019 and September 29, 2018, respectively.
Vendor Non-Trade Receivables
The Company has non-trade receivables from certain of its manufacturing vendors resulting from the sale of components to these vendors who manufacture sub-assemblies or assemble final products for the Company. The Company purchases these components directly from suppliers. As of June 29, 2019, the Company had three vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 57%, 12% and 12%. As of September 29, 2018, the Company had two vendors that individually represented 10% or more of total vendor non-trade receivables, which accounted for 62% and 12%.
v3.19.2
Condensed Consolidated Financial Statement Details
9 Months Ended
Jun. 29, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Condensed Consolidated Financial Statement Details Condensed Consolidated Financial Statement Details
The following tables show the Company’s condensed consolidated financial statement details as of June 29, 2019 and September 29, 2018 (in millions):
Property, Plant and Equipment, Net
 
June 29,
2019
 
September 29,
2018
Land and buildings
$
16,560

 
$
16,216

Machinery, equipment and internal-use software
68,529

 
65,982

Leasehold improvements
8,895

 
8,205

Gross property, plant and equipment
93,984

 
90,403

Accumulated depreciation and amortization
(56,348
)
 
(49,099
)
Total property, plant and equipment, net
$
37,636

 
$
41,304


Other Non-Current Liabilities
 
June 29,
2019
 
September 29,
2018
Long-term taxes payable
$
30,521

 
$
33,589

Other non-current liabilities
20,622

 
15,325

Total other non-current liabilities
$
51,143

 
$
48,914


Other Income/(Expense), Net
The following table shows the detail of other income/(expense), net for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (in millions):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Interest and dividend income
$
1,190

 
$
1,418

 
$
3,855

 
$
4,375

Interest expense
(866
)
 
(846
)
 
(2,766
)
 
(2,372
)
Other income/(expense), net
43

 
100

 
216

 
(301
)
Total other income/(expense), net
$
367

 
$
672

 
$
1,305

 
$
1,702


v3.19.2
Income Taxes
9 Months Ended
Jun. 29, 2019
Income Tax Disclosure [Abstract]  
Income Taxes Income Taxes
Uncertain Tax Positions
As of June 29, 2019, the total amount of gross unrecognized tax benefits was $14.8 billion, of which $8.1 billion, if recognized, would impact the Company’s effective tax rate. The Company had accrued $1.3 billion of gross interest and penalties as of June 29, 2019. Both the unrecognized tax benefits and the associated interest and penalties that are not expected to result in payment or receipt of cash within one year are classified as other non-current liabilities in the Condensed Consolidated Balance Sheet.
The Company is subject to taxation and files income tax returns in the U.S. federal jurisdiction and in many state and foreign jurisdictions. The U.S. Internal Revenue Service concluded its review of the years 2013 through 2015 in 2018, and all years prior to 2016 are closed. Tax years subsequent to 2006 in certain major U.S. states and subsequent to 2010 in certain major foreign jurisdictions remain open, and could be subject to examination by the taxing authorities. The Company believes that an adequate provision has been made for any adjustments that may result from tax examinations. However, the outcome of tax audits cannot be predicted with certainty. If any issues addressed in the Company’s tax audits are resolved in a manner inconsistent with its expectations, the Company could be required to adjust its provision for income taxes in the period such resolution occurs. Although timing of resolution and/or closure of audits is not certain, the Company believes it is reasonably possible that its gross unrecognized tax benefits could decrease (either by payment, release or a combination of both) in the next 12 months by as much as $400 million.
European Commission State Aid Decision
On August 30, 2016, the European Commission announced its decision that Ireland granted state aid to the Company by providing tax opinions in 1991 and 2007 concerning the tax allocation of profits of the Irish branches of two subsidiaries of the Company (the “State Aid Decision”). The State Aid Decision ordered Ireland to calculate and recover additional taxes from the Company for the period June 2003 through December 2014. The recovery amount was calculated to be €13.1 billion, plus interest of €1.2 billion. Irish legislative changes, effective as of January 2015, eliminated the application of the tax opinions from that date forward. The Company believes the State Aid Decision to be without merit and appealed to the General Court of the Court of Justice of the European Union. Ireland has also appealed the State Aid Decision. The Company believes that any incremental Irish corporate income taxes potentially due related to the State Aid Decision would be creditable against U.S. taxes, subject to any foreign tax credit limitations in the U.S. Tax Cuts and Jobs Act. As of June 29, 2019, the entire recovery amount plus interest was funded into escrow, where it will remain restricted from general use pending conclusion of all appeals. Refer to Note 3, “Financial Instruments” for more information.
v3.19.2
Debt
9 Months Ended
Jun. 29, 2019
Debt Disclosure [Abstract]  
Debt Debt
Commercial Paper
The Company issues unsecured short-term promissory notes (“Commercial Paper”) pursuant to a commercial paper program. The Company uses net proceeds from the commercial paper program for general corporate purposes, including dividends and share repurchases. As of June 29, 2019 and September 29, 2018, the Company had $10.0 billion and $12.0 billion of Commercial Paper outstanding, respectively, with maturities generally less than nine months. The weighted-average interest rate of the Company’s Commercial Paper was 2.49% and 2.18% as of June 29, 2019 and September 29, 2018, respectively. The following table provides a summary of cash flows associated with the issuance and maturities of Commercial Paper for the nine months ended June 29, 2019 and June 30, 2018 (in millions):
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
Maturities 90 days or less:
 
 
 
Proceeds from/(Repayments of) commercial paper, net
$
(3,720
)
 
$
2,619

 
 
 
 
Maturities greater than 90 days:
 
 
 
Proceeds from commercial paper
12,977

 
9,782

Repayments of commercial paper
(11,283
)
 
(12,411
)
Proceeds from/(Repayments of) commercial paper, net
1,694

 
(2,629
)
 
 
 
 
Total repayments of commercial paper, net
$
(2,026
)
 
$
(10
)

Term Debt
As of June 29, 2019, the Company had outstanding floating- and fixed-rate notes with varying maturities for an aggregate principal amount of $98.3 billion (collectively the “Notes”). The Notes are senior unsecured obligations, and interest is payable in arrears, quarterly for the U.S. dollar–denominated and Australian dollar–denominated floating-rate notes, semi-annually for the U.S. dollar–denominated, Australian dollar–denominated, British pound–denominated, Japanese yen–denominated and Canadian dollar–denominated fixed-rate notes and annually for the euro-denominated and Swiss franc–denominated fixed-rate notes.
The following table provides a summary of the Company’s term debt as of June 29, 2019 and September 29, 2018:
 
Maturities
(calendar year)
 
June 29, 2019
 
September 29, 2018
 
Amount
(in millions)
 
Effective
Interest Rate
 
Amount
(in millions)
 
Effective
Interest Rate
2013 debt issuance of $17.0 billion:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed-rate 2.400% – 3.850% notes
2023
2043
 
$
8,500

 
 
2.44%
3.91
%
 
$
8,500

 
 
2.44%
3.91
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2014 debt issuance of $12.0 billion:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Floating-rate notes
 
 
 

 
 
 
 
%
 
1,000

 
 
 
 
2.64
%
Fixed-rate 2.850% – 4.450% notes
2021
2044
 
6,500

 
 
3.12%
4.48
%
 
8,500

 
 
2.64%
4.48
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2015 debt issuances of $27.3 billion:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Floating-rate notes
2019
2020
 
1,488

 
 
1.87%
2.84
%
 
1,507

 
 
1.87%
2.64
%
Fixed-rate 0.350% – 4.375% notes
2019
2045
 
24,223

 
 
0.28%
4.51
%
 
24,410

 
 
0.28%
4.51
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2016 debt issuances of $24.9 billion:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Floating-rate notes
2019
2021
 
850

 
 
2.71%
3.65
%
 
1,350

 
 
2.48%
3.44
%
Fixed-rate 1.100% – 4.650% notes
2019
2046
 
22,022

 
 
1.13%
4.78
%
 
23,059

 
 
1.13%
4.78
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2017 debt issuances of $28.7 billion:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Floating-rate notes
2020
2022
 
2,750

 
 
2.61%
3.06
%
 
3,250

 
 
2.41%
2.84
%
Fixed-rate 0.875% – 4.300% notes
2019
2047
 
24,989

 
 
1.54%
4.30
%
 
25,617

 
 
1.54%
4.30
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2018 debt issuance of $7.0 billion:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed-rate 1.800% – 3.750% notes
2019
2047
 
7,000

 
 
1.83%
3.80
%
 
7,000

 
 
1.83%
3.80
%
Total term debt
 
 
 
 
98,322

 
 
 
 
 
 
104,193

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unamortized premium/(discount) and issuance costs, net
 
 
 
 
(194
)
 
 
 
 
 
 
(218
)
 
 
 
 
 
Hedge accounting fair value adjustments
 
 
 
 
337

 
 
 
 
 
 
(1,456
)
 
 
 
 
 
Less: Current portion of term debt
 
 
 
 
(13,529
)
 
 
 
 
 
 
(8,784
)
 
 
 
 
 
Total non-current portion of term debt
 
 
 
 
$
84,936

 
 
 
 
 
 
$
93,735

 
 
 
 
 
To manage interest rate risk on certain of its U.S. dollar–denominated fixed- or floating-rate notes, the Company has entered into interest rate swaps to effectively convert the fixed interest rates to floating interest rates or the floating interest rates to fixed interest rates on a portion of these notes. Additionally, to manage foreign currency risk on certain of its foreign currency–denominated notes, the Company has entered into foreign currency swaps to effectively convert these notes to U.S. dollar–denominated notes.
A portion of the Company’s Japanese yen–denominated notes is designated as a hedge of the foreign currency exposure of the Company’s net investment in a foreign operation. As of June 29, 2019 and September 29, 2018, the carrying value of the debt designated as a net investment hedge was $1.2 billion and $811 million, respectively. For further discussion regarding the Company’s use of derivative instruments, refer to the Derivative Financial Instruments section of Note 3, “Financial Instruments.”
The effective interest rates for the Notes include the interest on the Notes, amortization of the discount or premium and, if applicable, adjustments related to hedging. The Company recognized $790 million and $2.4 billion of interest cost on its term debt for the three- and nine-month periods ended June 29, 2019, respectively. The Company recognized $780 million and $2.2 billion of interest cost on its term debt for the three- and nine-month periods ended June 30, 2018, respectively.
As of June 29, 2019 and September 29, 2018, the fair value of the Company’s Notes, based on Level 2 inputs, was $102.5 billion and $103.2 billion, respectively.
v3.19.2
Shareholders' Equity
9 Months Ended
Jun. 29, 2019
Equity [Abstract]  
Shareholders' Equity Shareholders’ Equity
On April 30, 2019, the Company announced the Board of Directors increased the current share repurchase program authorization from $100 billion to $175 billion of the Company’s common stock, of which $78.2 billion had been utilized as of June 29, 2019. During the nine months ended June 29, 2019, the Company repurchased 252.6 million shares of its common stock for $49.2 billion, including 55.1 million shares initially delivered under a $12.0 billion accelerated share repurchase arrangement dated February 2019. The Company’s share repurchase program does not obligate it to acquire any specific number of shares. Under this program, shares may be repurchased in privately negotiated and/or open market transactions, including under plans complying with Rule 10b5-1 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”).
v3.19.2
Comprehensive Income
9 Months Ended
Jun. 29, 2019
Equity [Abstract]  
Comprehensive Income Comprehensive Income
The Company’s OCI consists of foreign currency translation adjustments from those subsidiaries not using the U.S. dollar as their functional currency, net deferred gains and losses on certain derivative instruments accounted for as cash flow hedges and unrealized gains and losses on marketable debt securities classified as available-for-sale.
The following table shows the pre-tax amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (in millions):
 
 
 
 
Three Months Ended
 
Nine Months Ended
Comprehensive Income Components
 
Financial Statement Line Item
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Unrealized (gains)/losses on derivative instruments:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
Total net sales
 
$
(68
)
 
$
162

 
$
(102
)
 
$
433

 
 
Total cost of sales
 
13

 
206

 
(438
)
 
200

 
 
Other income/(expense), net
 
3

 
864

 
451

 
441

Interest rate contracts
 
Other income/(expense), net
 
2

 

 
5

 
(3
)
 
 
 
 
(50
)
 
1,232

 
(84
)
 
1,071

Unrealized (gains)/losses on marketable securities
 
Other income/(expense), net
 
(28
)
 
31

 
55

 
(49
)
Total amounts reclassified from AOCI
 
$
(78
)
 
$
1,263

 
$
(29
)
 
$
1,022


The following table shows the changes in AOCI by component for the nine months ended June 29, 2019 (in millions):
 
Cumulative Foreign
Currency Translation
 
Unrealized Gains/Losses
on Derivative Instruments
 
Unrealized Gains/Losses
on Marketable Securities
 
Total
Balances as of September 29, 2018
$
(1,055
)
 
$
810

 
$
(3,209
)
 
$
(3,454
)
Other comprehensive income/(loss) before reclassifications
(136
)
 
(678
)
 
4,340

 
3,526

Amounts reclassified from AOCI

 
(84
)
 
55

 
(29
)
Tax effect
13

 
163

 
(947
)
 
(771
)
Other comprehensive income/(loss)
(123
)
 
(599
)
 
3,448

 
2,726

Cumulative effect of change in accounting principle (1)

 

 
89

 
89

Balances as of June 29, 2019
$
(1,178
)
 
$
211

 
$
328

 
$
(639
)

(1)
Refer to Note 1, “Summary of Significant Accounting Policies” for more information on the Company’s adoption of ASU 2016-01 at the beginning of the first quarter of 2019.
v3.19.2
Benefit Plans
9 Months Ended
Jun. 29, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Benefit Plans Benefit Plans
Stock Plans
The Company had 247.8 million shares reserved for future issuance under its stock plans as of June 29, 2019. Restricted stock units (“RSUs”) granted under the Company’s stock plans generally vest over four years, based on continued employment, and are settled upon vesting in shares of the Company’s common stock on a one-for-one basis. Each share issued with respect to RSUs granted under the Company’s stock plans reduces the number of shares available for grant under the plans by two shares. RSUs canceled and shares withheld to satisfy tax withholding obligations increase the number of shares available for grant under the plans utilizing a factor of two times the number of RSUs canceled or shares withheld.
Rule 10b5-1 Trading Plans
During the three months ended June 29, 2019, Section 16 officers Timothy D. Cook, Chris Kondo, Luca Maestri, Deirdre O’Brien and Jeffrey Williams had equity trading plans in place in accordance with Rule 10b5-1(c)(1) under the Exchange Act. An equity trading plan is a written document that pre-establishes the amounts, prices and dates (or formula for determining the amounts, prices and dates) of future purchases or sales of the Company’s stock, including shares acquired pursuant to the Company’s employee and director equity plans.
Restricted Stock Units
A summary of the Company’s RSU activity and related information for the nine months ended June 29, 2019 is as follows:
 
Number of
RSUs
(in thousands)
 
Weighted-Average
Grant Date Fair
Value Per RSU
 
Aggregate
Fair Value
(in millions)
Balance as of September 29, 2018
92,155

 
$
134.60

 
 
RSUs granted
34,805

 
$
216.40

 
 
RSUs vested
(39,440
)
 
$
135.82

 
 
RSUs canceled
(4,478
)
 
$
161.14

 
 
Balance as of June 29, 2019
83,042

 
$
166.87

 
$
16,436


The fair value as of the respective vesting dates of RSUs was $3.7 billion and $8.1 billion for the three- and nine-month periods ended June 29, 2019, respectively, and was $3.3 billion and $6.9 billion for the three- and nine-month periods ended June 30, 2018, respectively.
Share-Based Compensation
The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (in millions): 
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Share-based compensation expense
$
1,496

 
$
1,351

 
$
4,569

 
$
3,995

Income tax benefit related to share-based compensation expense
$
(502
)
 
$
(528
)
 
$
(1,583
)
 
$
(1,506
)

As of June 29, 2019, the total unrecognized compensation cost related to outstanding RSUs and stock options was $11.6 billion, which the Company expects to recognize over a weighted-average period of 2.6 years.
v3.19.2
Commitments and Contingencies
9 Months Ended
Jun. 29, 2019
Commitments and Contingencies Disclosure [Abstract]  
Commitments and Contingencies Commitments and Contingencies
Accrued Warranty and Indemnification
The following table shows changes in the Company’s accrued warranties and related costs for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (in millions):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Beginning accrued warranty and related costs
$
3,487

 
$
4,030

 
$
3,692

 
$
3,834

Cost of warranty claims
(912
)
 
(1,044
)
 
(2,823
)
 
(2,959
)
Accruals for product warranty
548

 
567

 
2,254

 
2,678

Ending accrued warranty and related costs
$
3,123

 
$
3,553

 
$
3,123

 
$
3,553


Agreements entered into by the Company may include indemnification provisions, which may subject the Company to costs and damages in the event of a claim against an indemnified third party. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss in excess of a recorded accrual, with respect to indemnification of third parties.
The Company offers an iPhone Upgrade Program, which is available to customers who purchase a qualifying iPhone in the U.S., the U.K. and mainland China. The iPhone Upgrade Program provides customers the right to trade in that iPhone for a specified amount when purchasing a new iPhone, provided certain conditions are met. The Company accounts for the trade-in right as a guarantee liability and recognizes arrangement revenue net of the fair value of such right, with subsequent changes to the guarantee liability recognized within net sales.
The Company has entered into indemnification agreements with its directors and executive officers. Under these agreements, the Company has agreed to indemnify such individuals to the fullest extent permitted by law against liabilities that arise by reason of their status as directors or officers of the Company, and to advance expenses incurred by such individuals in connection with related legal proceedings. It is not possible to determine the maximum potential amount of payments the Company could be required to make under these agreements due to the limited history of prior indemnification claims and the unique facts and circumstances involved in each claim. While the Company maintains directors and officers liability insurance coverage, such insurance coverage may be insufficient to cover all losses or all types of claims that may arise.
Concentrations in the Available Sources of Supply of Materials and Product
Although most components essential to the Company’s business are generally available from multiple sources, certain components are currently obtained from single or limited sources. In addition, the Company competes for various components with other participants in the markets for mobile communication and media devices and personal computers. Therefore, many components used by the Company, including those that are available from multiple sources, are at times subject to industry-wide shortage and significant commodity pricing fluctuations that could materially adversely affect the Company’s financial condition and operating results.
The Company uses some custom components that are not commonly used by its competitors, and new products introduced by the Company often utilize custom components available from only one source. When a component or product uses new technologies, initial capacity constraints may exist until the suppliers’ yields have matured or manufacturing capacity has increased. If the Company’s supply of components for a new or existing product were delayed or constrained, or if an outsourcing partner delayed shipments of completed products to the Company, the Company’s financial condition and operating results could be materially adversely affected. The Company’s business and financial performance could also be materially adversely affected depending on the time required to obtain sufficient quantities from the original source, or to identify and obtain sufficient quantities from an alternative source. Continued availability of these components at acceptable prices, or at all, may be affected if suppliers decide to concentrate on the production of common components instead of components customized to meet the Company’s requirements.
The Company has entered into agreements for the supply of many components; however, there can be no guarantee that the Company will be able to extend or renew these agreements on similar terms, or at all. Therefore, the Company remains subject to significant risks of supply shortages and price increases that could materially adversely affect its financial condition and operating results.
Substantially all of the Company’s hardware products are manufactured by outsourcing partners that are located primarily in Asia, with some Mac computers manufactured in the U.S. and Ireland. A significant concentration of this manufacturing is currently performed by a small number of outsourcing partners, often in single locations. Certain of these outsourcing partners are single-sourced suppliers of components and manufacturers for many of the Company’s products. Although the Company works closely with its outsourcing partners on manufacturing schedules, the Company’s financial condition and operating results could be materially adversely affected if its outsourcing partners were unable to meet their production commitments. The Company’s manufacturing purchase obligations typically cover its requirements for periods up to 150 days.
Other Off–Balance Sheet Commitments
Operating Leases
The Company leases various equipment and facilities, including retail space, under noncancelable operating lease arrangements. The Company does not currently utilize any other off–balance sheet financing arrangements. As of June 29, 2019, the Company’s total future minimum lease payments under noncancelable operating leases were $11.1 billion. The Company’s retail store and other facility leases typically have original terms not exceeding 10 years and generally contain multi-year renewal options.
Unconditional Purchase Obligations
The Company has entered into certain off–balance sheet commitments that require the future purchase of goods or services (“unconditional purchase obligations”). The Company’s unconditional purchase obligations primarily consist of payments for supplier arrangements, internet and telecommunication services, intellectual property licenses and content creation. As of June 29, 2019, the Company’s total future payments under noncancelable unconditional purchase obligations having a remaining term in excess of one year were $8.1 billion.
Contingencies
The Company is subject to various legal proceedings and claims that have arisen in the ordinary course of business and that have not been fully adjudicated, as further discussed in Part II, Item 1 of this Form 10-Q under the heading “Legal Proceedings” and in Part II, Item 1A of this Form 10-Q under the heading “Risk Factors.” The outcome of litigation is inherently uncertain. If one or more legal matters were resolved against the Company in a reporting period for amounts in excess of management’s expectations, the Company’s financial condition and operating results for that reporting period could be materially adversely affected. In the opinion of management, there was not at least a reasonable possibility the Company may have incurred a material loss, or a material loss in excess of a recorded accrual, with respect to loss contingencies for asserted legal and other claims, except for the following matters:
VirnetX
VirnetX, Inc. (“VirnetX”) filed two lawsuits in the U.S. District Court for the Eastern District of Texas (the “Eastern Texas District Court”) against the Company alleging that certain Company products infringe four patents (the “VirnetX Patents”) relating to network communications technology (“VirnetX I” and “VirnetX II”). On September 30, 2016, a jury returned a verdict in VirnetX I against the Company and awarded damages of $302 million, which later increased to $440 million in post-trial proceedings. The Company appealed the VirnetX I verdict to the U.S. Court of Appeals for the Federal Circuit (the “Federal Circuit”). On April 11, 2018, a jury returned a verdict in VirnetX II against the Company and awarded damages of $503 million. VirnetX II is currently on appeal. The Company has challenged the validity of the VirnetX Patents at the U.S. Patent and Trademark Office (the “PTO”). In response, the PTO has declared the VirnetX Patents invalid. VirnetX appealed the invalidity decision of the PTO to the Federal Circuit. The Federal Circuit consolidated the Company’s appeal of the Eastern Texas District Court VirnetX I verdict and VirnetX’s appeals from the PTO invalidity proceedings. On January 15, 2019, the Federal Circuit affirmed the VirnetX I verdict, which the Company intends to further appeal. On July 8, 2019, the Federal Circuit remanded one of VirnetX’s appeals of the PTO’s invalidity decisions back to the PTO for further proceedings. VirnetX’s other remaining appeal of the PTO’s invalidity decisions remains pending with the Federal Circuit. The Company has accrued its best estimate for the ultimate resolution of these matters.
Qualcomm
On January 20, 2017, the Company filed a lawsuit against Qualcomm Incorporated and affiliated parties (“Qualcomm”) in the U.S. District Court for the Southern District of California seeking, among other things, to enjoin Qualcomm from requiring the Company to pay royalties at the rate demanded by Qualcomm. No Qualcomm-related royalty payments had been remitted by the Company to its contract manufacturers since the beginning of the second quarter of 2017. Following the Company’s lawsuit, Qualcomm filed patent infringement suits against the Company and its affiliates in the U.S. and various international jurisdictions, some of which sought to enjoin the sale of certain of the Company’s products in particular countries.
On April 16, 2019, the Company and Qualcomm reached a settlement agreement to dismiss all litigation between the two companies worldwide. The companies also reached a multi-year license agreement and a multi-year supply agreement. Under the terms of the settlement agreement, Apple made a payment to Qualcomm to, among other things, resolve disputes over the withheld royalty payments.
iOS Performance Management Cases
Various civil litigation matters have been filed in state and federal courts in the U.S. and in various international jurisdictions alleging violation of consumer protection laws, fraud, computer intrusion and other causes of action related to the Company’s performance management feature used in its iPhone operating systems, introduced to certain iPhones in iOS updates 10.2.1 and 11.2. The claims seek monetary damages and other non-monetary relief. On April 5, 2018, several U.S. federal actions were consolidated through a Multidistrict Litigation process into a single action in the U.S. District Court for the Northern District of California. In addition to civil litigation, the Company is also responding to governmental investigations and requests for information relating to the performance management feature. The Company believes that its iPhones were not defective, that the performance management feature introduced with iOS updates 10.2.1 and 11.2 was intended to, and did, improve customers’ user experience, and that the Company did not make any misleading statements or fail to disclose any material information. The Company has accrued its best estimate for the ultimate resolution of these matters.
v3.19.2
Segment Information and Geographic Data
9 Months Ended
Jun. 29, 2019
Segment Reporting [Abstract]  
Segment Information and Geographic Data Segment Information and Geographic Data
The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company’s reportable segments.
The Company manages its business primarily on a geographic basis. The Company’s reportable segments consist of the Americas, Europe, Greater China, Japan and Rest of Asia Pacific. Americas includes both North and South America. Europe includes European countries, as well as India, the Middle East and Africa. Greater China includes China, Hong Kong and Taiwan. Rest of Asia Pacific includes Australia and those Asian countries not included in the Company’s other reportable segments. Although the reportable segments provide similar hardware and software products and similar services, each one is managed separately to better align with the location of the Company’s customers and distribution partners and the unique market dynamics of each geographic region. The accounting policies of the various segments are the same as those described in Note 1, “Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements in Part II, Item 8 of the 2018 Form 10-K.
The Company evaluates the performance of its reportable segments based on net sales and operating income. Net sales for geographic segments are generally based on the location of customers and sales through the Company’s retail stores located in those geographic locations. Operating income for each segment includes net sales to third parties, related cost of sales and operating expenses directly attributable to the segment. Advertising expenses are generally included in the geographic segment in which the expenditures are incurred. Operating income for each segment excludes other income and expense and certain expenses managed outside the reportable segments. Costs excluded from segment operating income include various corporate expenses such as research and development, corporate marketing expenses, certain share-based compensation expenses, income taxes, various nonrecurring charges and other separately managed general and administrative costs. The Company does not include intercompany transfers between segments for management reporting purposes.
The following table shows information by reportable segment for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (in millions):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Americas:
 
 
 
 
 
 
 
Net sales
$
25,056

 
$
24,542

 
$
87,592

 
$
84,576

Operating income
$
7,442

 
$
7,496

 
$
26,329

 
$
26,580

 
 
 
 
 
 
 
 
Europe:
 
 
 
 
 
 
 
Net sales
$
11,925

 
$
12,138

 
$
45,342

 
$
47,038

Operating income
$
3,687

 
$
3,892

 
$
14,371

 
$
15,044

 
 
 
 
 
 
 
 
Greater China:
 
 
 
 
 
 
 
Net sales
$
9,157

 
$
9,551

 
$
32,544

 
$
40,531

Operating income
$
3,221

 
$
3,414

 
$
12,142

 
$
15,285

 
 
 
 
 
 
 
 
Japan:
 
 
 
 
 
 
 
Net sales
$
4,082

 
$
3,867

 
$
16,524

 
$
16,572

Operating income
$
1,795

 
$
1,765

 
$
7,199

 
$
7,193

 
 
 
 
 
 
 
 
Rest of Asia Pacific:
 
 
 
 
 
 
 
Net sales
$
3,589

 
$
3,167

 
$
14,132

 
$
13,978

Operating income
$
1,155

 
$
1,127

 
$
4,811

 
$
4,980


A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 is as follows (in millions):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Segment operating income
$
17,300

 
$
17,694

 
$
64,852

 
$
69,082

Research and development expense
(4,257
)
 
(3,701
)
 
(12,107
)
 
(10,486
)
Other corporate expenses, net
(1,499
)
 
(1,381
)
 
(4,440
)
 
(3,816
)
Total operating income
$
11,544

 
$
12,612

 
$
48,305

 
$
54,780


v3.19.2
Summary of Significant Accounting Policies (Policies)
9 Months Ended
Jun. 29, 2019
Accounting Policies [Abstract]  
Basis of Presentation and Preparation
Basis of Presentation and Preparation
The accompanying condensed consolidated financial statements include the accounts of Apple Inc. and its wholly owned subsidiaries (collectively “Apple” or the “Company”). Intercompany accounts and transactions have been eliminated. In the opinion of the Company’s management, the condensed consolidated financial statements reflect all adjustments, which are normal and recurring in nature, necessary for fair financial statement presentation. The preparation of these condensed consolidated financial statements and accompanying notes in conformity with U.S. generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements and accompanying notes have been reclassified to conform to the current period’s presentation. These condensed consolidated financial statements and accompanying notes should be read in conjunction with the Company’s annual consolidated financial statements and the notes thereto included in its Annual Report on Form 10-K for the fiscal year ended September 29, 2018 (the “2018 Form 10-K”).
Fiscal Period
The Company’s fiscal year is the 52- or 53-week period that ends on the last Saturday of September. A 14th week is included in the first fiscal quarter every five or six years to realign the Company’s fiscal quarters with calendar quarters. The Company’s fiscal years 2019 and 2018 span 52 weeks each. Unless otherwise stated, references to particular years, quarters, months and periods refer to the Company’s fiscal years ended in September and the associated quarters, months and periods of those fiscal years.
New Accounting Pronouncements
Revenue Recognition
In the first quarter of 2019, the Company adopted the Financial Accounting Standards Board’s (the “FASB”) Accounting Standards Update (“ASU”) No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”), and additional ASUs issued to clarify the guidance in ASU 2014-09 (collectively the “new revenue standard”), which amends the existing accounting standards for revenue recognition. The Company adopted the new revenue standard utilizing the full retrospective transition method. The Company did not restate total net sales in the prior periods presented, as adoption of the new revenue standard did not have a material impact on previously reported amounts.
Additionally, beginning in the first quarter of 2019, the Company classified the amortization of the deferred value of Maps, Siri® and free iCloud® services, which are bundled in the sales price of iPhone®, Mac®, iPad® and certain other products, in services net sales. Historically, the Company classified the amortization of these amounts in products net sales consistent with its management reporting framework. As a result, products and services net sales information for the third quarter and first nine months of 2018 was reclassified to conform to the 2019 presentation.
Financial Instruments
In the first quarter of 2019, the Company adopted FASB ASU No. 2016-01, Financial Instruments – Overall (Subtopic 825-10): Recognition and Measurement of Financial Assets and Financial Liabilities (“ASU 2016-01”), which updates certain aspects of the recognition, measurement, presentation and disclosure of financial instruments. The adoption of ASU 2016-01 did not have a material impact on the Company’s condensed consolidated financial statements.
Income Taxes
In the first quarter of 2019, the Company adopted FASB ASU No. 2016-16, Income Taxes (Topic 740): Intra-Entity Transfers of Assets Other Than Inventory (“ASU 2016-16”), which requires the recognition of the income tax consequences of an intra-entity transfer of an asset, other than inventory, when the transfer occurs. The Company adopted ASU 2016-16 utilizing the modified retrospective transition method. Upon adoption, the Company recorded $2.7 billion of net deferred tax assets, reduced other non-current assets by $128 million, and increased retained earnings by $2.6 billion on its Condensed Consolidated Balance Sheet. The Company will recognize incremental deferred income tax expense as these net deferred tax assets are utilized.
Restricted Cash
In the first quarter of 2019, the Company adopted FASB ASU No. 2016-18, Statement of Cash Flows (Topic 230): Restricted Cash (“ASU 2016-18”), which enhances and clarifies the guidance on the classification and presentation of restricted cash in the statement of cash flows and requires additional disclosures about restricted cash balances.
Restricted Cash and Marketable Securities
The Company considers cash and marketable securities to be restricted when withdrawal or general use is legally restricted. The Company records restricted cash as other assets in the Condensed Consolidated Balance Sheets, and determines current or non-current classification based on the expected duration of the restriction. The Company records restricted marketable securities as current or non-current marketable securities in the Condensed Consolidated Balance Sheets based on the classification of the underlying securities.
Revenue Recognition
Net sales consist of revenue from the sale of iPhone, Mac, iPad, services and other products. The Company recognizes revenue at the amount to which it expects to be entitled when control of the products or services is transferred to its customers. Control is generally transferred when the Company has a present right to payment and title and the significant risks and rewards of ownership of products or services are transferred to its customers. For most of the Company’s products net sales, control transfers when products are shipped. For the Company’s services net sales, control transfers over time as services are delivered. Payment for products and services net sales is collected within a short period of time following transfer of control or commencement of delivery of services, as applicable.
The Company records reductions to products net sales related to future product returns, price protection and other customer incentive programs based on the Company’s expectations and historical experience.
For arrangements with multiple performance obligations, which represent promises within an arrangement that are capable of being distinct, the Company allocates revenue to all distinct performance obligations based on their relative stand-alone selling prices (“SSP”). When available, the Company uses observable prices to determine the SSP. When observable prices are not available, SSPs are established that reflect the Company’s best estimates of what the selling prices of the performance obligations would be if they were sold regularly on a stand-alone basis. The Company’s process for estimating SSPs without observable prices considers multiple factors that may vary depending upon the unique facts and circumstances related to each performance obligation including, where applicable, prices charged by the Company for similar offerings, market trends in the pricing for similar offerings, product-specific business objectives and the estimated cost to provide the performance obligation.
The Company has identified up to three performance obligations regularly included in arrangements involving the sale of iPhone, Mac, iPad and certain other products. The first performance obligation, which represents the substantial portion of the allocated sales price, is the hardware and bundled software delivered at the time of sale. The second performance obligation is the right to receive certain product-related bundled services, which include iCloud, Siri and Maps. The third performance obligation is the right to receive, on a when-and-if-available basis, future unspecified software upgrades relating to the software bundled with each device. The Company allocates revenue and any related discounts to these performance obligations based on their relative SSPs. Because the Company lacks observable prices for the undelivered performance obligations, the allocation of revenue is based on the Company’s estimated SSPs. Revenue allocated to the delivered hardware and bundled software is recognized when control has transferred to the customer, which generally occurs when the product is shipped. Revenue allocated to the product-related bundled services and unspecified software upgrade rights is deferred and recognized on a straight-line basis over the estimated period they are expected to be provided. Cost of sales related to delivered hardware and bundled software, including estimated warranty costs, are recognized at the time of sale. Costs incurred to provide product-related bundled services and unspecified software upgrade rights are recognized as cost of sales as incurred.
For certain long-term service arrangements, the Company has performance obligations for services it has not yet delivered. For these arrangements, the Company does not have a right to bill for the undelivered services. The Company has determined that any unbilled consideration relates entirely to the value of the undelivered services. Accordingly, the Company has not recognized revenue, and has elected not to disclose amounts, related to these undelivered services.
For the sale of third-party products where the Company obtains control of the product before transferring it to the customer, the Company recognizes revenue based on the gross amount billed to customers. The Company considers multiple factors when determining whether it obtains control of third-party products including, but not limited to, evaluating if it has the ability to establish the price of the product, retains inventory risk for tangible products or has the responsibility for ensuring acceptability of the product. For third-party applications sold through the App Store®, Mac App Store and TV App Store and certain digital content sold through the iTunes Store®, the Company does not obtain control of the product before transferring it to the customer. Therefore, the Company accounts for such sales on a net basis by recognizing in services net sales only the commission it retains.
The Company has elected to record revenue net of taxes collected from customers that are remitted to governmental authorities, with the collected taxes recorded within other current liabilities until remitted to the relevant government authority.
Marketable Securities
The Company’s investments in marketable debt securities have been classified and accounted for as available-for-sale. The Company classifies its marketable debt securities as either short-term or long-term based on each instrument’s underlying contractual maturity date. Unrealized gains and losses on marketable debt securities classified as available-for-sale are recognized in other comprehensive income/(loss) (“OCI”).
The Company’s investments in marketable equity securities are classified based on the nature of the securities and their availability for use in current operations. The Company’s marketable equity securities are measured at fair value with gains and losses recognized in other income/(expense), net.
Fair Value Measurements
Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities.
Non-Marketable Securities The Company holds non-marketable equity securities of certain privately held companies without readily determinable fair values, and has elected to apply the measurement alternative. As such, the Company’s non-marketable equity securities are measured at cost, less any impairment, and are adjusted for changes in fair value resulting from observable transactions for identical or similar investments of the same issuer. Gains and losses on non-marketable equity securities are recognized in other income/(expense), net.
Derivative Financial Instruments
Derivative Financial Instruments
The Company may use derivatives to partially offset its business exposure to foreign currency and interest rate risk on expected future cash flows, net investments in certain foreign subsidiaries, and certain existing assets and liabilities. However, the Company may choose not to hedge certain exposures for a variety of reasons including, but not limited to, accounting considerations or the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency exchange or interest rates.
To protect gross margins from fluctuations in foreign currency exchange rates, certain of the Company’s subsidiaries whose functional currency is the U.S. dollar may hedge a portion of forecasted foreign currency revenue, and subsidiaries whose functional currency is not the U.S. dollar may hedge a portion of forecasted inventory purchases not denominated in the subsidiaries’ functional currencies. The Company may enter into forward contracts, option contracts or other instruments to manage this risk and may designate these instruments as cash flow hedges. The Company generally hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases, typically for up to 12 months.
To protect the net investment in a foreign operation from fluctuations in foreign currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset a portion of the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates. In addition, the Company may use non-derivative financial instruments, such as its foreign currency–denominated debt, as hedges of its net investments in certain foreign subsidiaries. In both of these cases, the Company designates these instruments as net investment hedges.
To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in foreign currency exchange rates, the Company may enter into forward contracts, cross-currency swaps or other instruments. These instruments may offset a portion of the foreign currency remeasurement gains or losses, or changes in fair value. The Company may designate these instruments as either cash flow or fair value hedges. As of June 29, 2019, the Company’s hedged term debt– and marketable securities–related foreign currency transactions are expected to be recognized within 23 years.
The Company may also enter into non-designated foreign currency contracts to offset a portion of the foreign currency exchange gains and losses generated by the remeasurement of certain assets and liabilities denominated in non-functional currencies.
To protect the Company’s foreign currency–denominated term debt or marketable securities from fluctuations in interest rates, the Company may enter into interest rate swaps, options or other instruments. These instruments may offset a portion of the changes in interest income or expense, or changes in fair value. The Company designates these instruments as either cash flow or fair value hedges. As of June 29, 2019, the Company’s hedged interest rate transactions are expected to be recognized within 8 years.
Cash Flow Hedges
The effective portions of cash flow hedges are recorded in accumulated other comprehensive income/(loss) (“AOCI”) until the hedged item is recognized in earnings. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are recognized. Deferred gains and losses associated with cash flow hedges of interest income or expense are recognized in other income/(expense), net in the same period as the related income or expense is recognized. For options designated as cash flow hedges, changes in the time value are excluded from the assessment of hedge effectiveness. The ineffective portions and amounts excluded from the effectiveness testing of cash flow hedges are recognized in other income/(expense), net.
Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified into other income/(expense), net in the period of de-designation. Any subsequent changes in fair value of such derivative instruments are reflected in other income/(expense), net unless they are re-designated as hedges of other transactions.
Net Investment Hedges
The effective portions of net investment hedges are recorded in OCI as a part of the cumulative translation adjustment. The ineffective portions and amounts excluded from the effectiveness testing of net investment hedges are recognized in other income/(expense), net. For foreign exchange forward contracts designated as net investment hedges, the Company excludes changes in fair value relating to changes in the forward carry component from its assessment of hedge effectiveness. Accordingly, any gains or losses related to this forward carry component are recognized in earnings in the current period.
Fair Value Hedges
Gains and losses related to changes in fair value hedges are recognized in earnings along with a corresponding loss or gain related to the change in value of the underlying hedged item in the same line in the Condensed Consolidated Statements of Operations. For foreign exchange forward contracts designated as fair value hedges, the Company excludes changes in fair value relating to changes in the forward carry component from its assessment of hedge effectiveness. Amounts excluded from the effectiveness testing of fair value hedges were gains of $171 million and $645 million for the three- and nine-month periods ended June 29, 2019, respectively, and were recognized in other income/(expense), net.
Non-Designated Derivatives
Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates.The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The Company’s accounting treatment for these derivative instruments is based on its hedge designation.
The Company classifies cash flows related to derivative financial instruments as operating activities in its Condensed Consolidated Statements of Cash Flows.
Segment Reporting
The Company reports segment information based on the “management” approach. The management approach designates the internal reporting used by management for making decisions and assessing performance as the source of the Company’s reportable segments.
The Company manages its business primarily on a geographic basis. The Company’s reportable segments consist of the Americas, Europe, Greater China, Japan and Rest of Asia Pacific. Americas includes both North and South America. Europe includes European countries, as well as India, the Middle East and Africa. Greater China includes China, Hong Kong and Taiwan. Rest of Asia Pacific includes Australia and those Asian countries not included in the Company’s other reportable segments. Although the reportable segments provide similar hardware and software products and similar services, each one is managed separately to better align with the location of the Company’s customers and distribution partners and the unique market dynamics of each geographic region. The accounting policies of the various segments are the same as those described in Note 1, “Summary of Significant Accounting Policies” of the Notes to Consolidated Financial Statements in Part II, Item 8 of the 2018 Form 10-K.
The Company evaluates the performance of its reportable segments based on net sales and operating income. Net sales for geographic segments are generally based on the location of customers and sales through the Company’s retail stores located in those geographic locations. Operating income for each segment includes net sales to third parties, related cost of sales and operating expenses directly attributable to the segment. Advertising expenses are generally included in the geographic segment in which the expenditures are incurred. Operating income for each segment excludes other income and expense and certain expenses managed outside the reportable segments. Costs excluded from segment operating income include various corporate expenses such as research and development, corporate marketing expenses, certain share-based compensation expenses, income taxes, various nonrecurring charges and other separately managed general and administrative costs. The Company does not include intercompany transfers between segments for management reporting purposes.
v3.19.2
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Jun. 29, 2019
Accounting Policies [Abstract]  
Computation of Basic and Diluted Earnings Per Share
The following table shows the computation of basic and diluted earnings per share for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (net income in millions and shares in thousands):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Numerator:
 
 
 
 
 
 
 
Net income
$
10,044

 
$
11,519

 
$
41,570

 
$
45,406

 
 
 
 
 
 
 
 
Denominator:
 
 
 
 
 
 
 
Weighted-average basic shares outstanding
4,570,633

 
4,882,167

 
4,660,175

 
5,006,640

Effect of dilutive securities
30,747

 
44,442

 
31,584

 
44,323

Weighted-average diluted shares
4,601,380

 
4,926,609

 
4,691,759

 
5,050,963

 
 
 
 
 
 
 
 
Basic earnings per share
$
2.20

 
$
2.36

 
$
8.92

 
$
9.07

Diluted earnings per share
$
2.18

 
$
2.34

 
$
8.86

 
$
8.99


v3.19.2
Revenue Recognition (Tables)
9 Months Ended
Jun. 29, 2019
Revenue from Contract with Customer [Abstract]  
Disaggregated Revenue
Net sales disaggregated by significant products and services for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 were as follows (in millions):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
iPhone (1)
$
25,986

 
$
29,470

 
$
109,019

 
$
128,133

Mac (1)
5,820

 
5,258

 
18,749

 
17,858

iPad (1)
5,023

 
4,634

 
16,624

 
14,397

Wearables, Home and Accessories (1)(2)
5,525

 
3,733

 
17,962

 
13,158

Services (3)
11,455

 
10,170

 
33,780

 
29,149

Total net sales (4)
$
53,809

 
$
53,265

 
$
196,134

 
$
202,695

(1)
Products net sales include amortization of the deferred value of unspecified software upgrade rights, which are bundled in the sales price of the respective product.
(2)
Wearables, Home and Accessories net sales include sales of AirPods®, Apple TV®, Apple Watch®, Beats® products, HomePod™, iPod touch® and Apple-branded and third-party accessories.
(3)
Services net sales include sales from the Company’s digital content stores and streaming services, AppleCare®, Apple Pay®, licensing and other services. Services net sales also include amortization of the deferred value of Maps, Siri and free iCloud services, which are bundled in the sales price of certain products.
(4)
Includes $2.0 billion of revenue recognized in the three months ended June 29, 2019 that was included in deferred revenue as of March 30, 2019, $2.0 billion of revenue recognized in the three months ended June 30, 2018 that was included in deferred revenue as of March 31, 2018, $4.9 billion of revenue recognized in the nine months ended June 29, 2019 that was included in deferred revenue as of September 29, 2018, and $4.7 billion of revenue recognized in the nine months ended June 30, 2018 that was included in deferred revenue as of September 30, 2017.
v3.19.2
Financial Instruments (Tables)
9 Months Ended
Jun. 29, 2019
Investments, All Other Investments [Abstract]  
Cash and Available-for-Sale Securities by Significant Investment Category
The following tables show the Company’s cash and marketable securities by significant investment category as of June 29, 2019 and September 29, 2018 (in millions):
 
June 29, 2019
 
Adjusted
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair
Value
 
Cash and
Cash
Equivalents
 
Short-Term
Marketable
Securities
 
Long-Term
Marketable
Securities
Cash
$
12,075

 
$

 
$

 
$
12,075

 
$
12,075

 
$

 
$

Level 1 (1):
 
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds
10,558

 

 

 
10,558

 
10,558

 

 

Subtotal
10,558

 

 

 
10,558

 
10,558

 

 

Level 2 (2):
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Treasury securities
37,307

 
22

 
(102
)
 
37,227

 
11,116

 
8,436

 
17,675

U.S. agency securities
9,552

 
1

 
(5
)
 
9,548

 
7,711

 
450

 
1,387

Non-U.S. government securities
20,569

 
272

 
(63
)
 
20,778

 
636

 
3,467

 
16,675

Certificates of deposit and time deposits
4,838

 

 

 
4,838

 
3,495

 
1,273

 
70

Commercial paper
5,161

 

 

 
5,161

 
4,930

 
231

 

Corporate debt securities
93,896

 
550

 
(173
)
 
94,273

 
9

 
29,027

 
65,237

Municipal securities
961

 
9

 
(1
)
 
969

 

 
65

 
904

Mortgage- and asset-backed securities
15,262

 
38

 
(117
)
 
15,183

 

 
1,135

 
14,048

Subtotal
187,546

 
892

 
(461
)
 
187,977

 
27,897

 
44,084

 
115,996

Total (3)
$
210,179

 
$
892

 
$
(461
)
 
$
210,610

 
$
50,530

 
$
44,084

 
$
115,996

 
September 29, 2018
 
Adjusted
Cost
 
Unrealized
Gains
 
Unrealized
Losses
 
Fair
Value
 
Cash and
Cash
Equivalents
 
Short-Term
Marketable
Securities
 
Long-Term
Marketable
Securities
Cash
$
11,575

 
$

 
$

 
$
11,575

 
$
11,575

 
$

 
$

Level 1 (1):
 
 
 
 
 
 
 
 
 
 
 
 
 
Money market funds
8,083

 

 

 
8,083

 
8,083

 

 

Mutual funds
799

 

 
(116
)
 
683

 

 
683

 

Subtotal
8,882

 

 
(116
)
 
8,766

 
8,083

 
683

 

Level 2 (2):
 
 
 
 
 
 
 
 
 
 
 
 
 
U.S. Treasury securities
47,296

 

 
(1,202
)
 
46,094

 
1,613

 
7,606

 
36,875

U.S. agency securities
4,127

 

 
(48
)
 
4,079

 
1,732

 
360

 
1,987

Non-U.S. government securities
21,601

 
49

 
(250
)
 
21,400

 

 
3,355

 
18,045

Certificates of deposit and time deposits
3,074

 

 

 
3,074

 
1,247

 
1,330

 
497

Commercial paper
2,573

 

 

 
2,573

 
1,663

 
910

 

Corporate debt securities
123,001

 
152

 
(2,038
)
 
121,115

 

 
25,162

 
95,953

Municipal securities
946

 

 
(12
)
 
934

 

 
178

 
756

Mortgage- and asset-backed securities
18,105

 
8

 
(623
)
 
17,490

 

 
804

 
16,686

Subtotal
220,723

 
209

 
(4,173
)
 
216,759

 
6,255

 
39,705

 
170,799

Total (3)
$
241,180

 
$
209

 
$
(4,289
)
 
$
237,100

 
$
25,913

 
$
40,388

 
$
170,799

(1)
Level 1 fair value estimates are based on quoted prices in active markets for identical assets or liabilities.
(2)
Level 2 fair value estimates are based on observable inputs other than quoted prices in active markets for identical assets and liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
(3)
As of June 29, 2019 and September 29, 2018, total cash, cash equivalents and marketable securities included $19.5 billion and $20.3 billion, respectively, that was restricted from general use, related to the State Aid Decision (refer to Note 5, “Income Taxes”) and other agreements.
Marketable Securities in a Continuous Unrealized Loss Position
The following tables show information about the Company’s marketable securities that had been in a continuous unrealized loss position for less than 12 months and for 12 months or greater as of June 29, 2019 and September 29, 2018 (in millions):
 
June 29, 2019
 
Continuous Unrealized Losses
 
Less than 12 Months
 
12 Months or Greater
 
Total
Fair value of marketable debt securities
$
11,853

 
$
71,984

 
$
83,837

Unrealized losses
$
(44
)
 
$
(417
)
 
$
(461
)
 
September 29, 2018
 
Continuous Unrealized Losses
 
Less than 12 Months
 
12 Months or Greater
 
Total
Fair value of marketable securities
$
126,238

 
$
60,599

 
$
186,837

Unrealized losses
$
(2,400
)
 
$
(1,889
)
 
$
(4,289
)

Cash, Cash Equivalents and Restricted Cash Reconciliation
A reconciliation of the Company’s cash and cash equivalents in the Condensed Consolidated Balance Sheet to cash, cash equivalents and restricted cash in the Condensed Consolidated Statement of Cash Flows as of June 29, 2019 is as follows (in millions):
 
June 29,
2019
Cash and cash equivalents
$
50,530

Restricted cash included in other current assets
266

Restricted cash included in other non-current assets
1,355

Cash, cash equivalents and restricted cash
$
52,151


Derivative Instruments at Gross Fair Value The following tables show the Company’s derivative instruments at gross fair value as of June 29, 2019 and September 29, 2018 (in millions):
 
June 29, 2019
 
Fair Value of
Derivatives Designated
as Hedge Instruments
 
Fair Value of
Derivatives Not Designated
as Hedge Instruments
 
Total
Fair Value
Derivative assets (1):
 
 
 
 
 
Foreign exchange contracts
$
1,179

 
$
184

 
$
1,363

Interest rate contracts
$
449

 
$

 
$
449

 
 
 
 
 
 
Derivative liabilities (2):
 
 
 
 
 
Foreign exchange contracts
$
860

 
$
251

 
$
1,111

Interest rate contracts
$
112

 
$

 
$
112

 
September 29, 2018
 
Fair Value of
Derivatives Designated
as Hedge Instruments
 
Fair Value of
Derivatives Not Designated
as Hedge Instruments
 
Total
Fair Value
Derivative assets (1):
 
 
 
 
 
Foreign exchange contracts
$
1,015

 
$
259

 
$
1,274

 
 
 
 
 
 
Derivative liabilities (2):
 
 
 
 
 
Foreign exchange contracts
$
543

 
$
137

 
$
680

Interest rate contracts
$
1,456

 
$

 
$
1,456

(1)
The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets and other non-current assets in the Condensed Consolidated Balance Sheets.
(2)
The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as other current liabilities and other non-current liabilities in the Condensed Consolidated Balance Sheets.
Pre-Tax Gains and Losses of Derivative and Non-Derivative Instruments Designated as Cash Flow, Net Investment and Fair Value Hedges
The following table shows the pre-tax gains and losses of the Company’s derivative and non-derivative instruments designated as cash flow, net investment and fair value hedges in OCI and the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (in millions):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Gains/(Losses) recognized in OCI – effective portion:
 
 
 
 
 
 
 
Cash flow hedges:
 
 
 
 
 
 
 
Foreign exchange contracts
$
(147
)
 
$
40

 
$
(689
)
 
$
230

Interest rate contracts

 

 

 
1

Total
$
(147
)
 
$
40

 
$
(689
)
 
$
231

 
 
 
 
 
 
 
 
Net investment hedges:
 
 
 
 
 
 
 
Foreign currency debt
$
(32
)
 
$
13

 
$
(55
)
 
$
(18
)
 
 
 
 
 
 
 
 
Gains/(Losses) reclassified from AOCI into net income – effective portion:
 
 
 
 
 
 
 
Cash flow hedges:
 
 
 
 
 
 
 
Foreign exchange contracts
$
53

 
$
(1,231
)
 
$
69

 
$
(1,068
)
Interest rate contracts
(2
)
 

 
(5
)
 
3

Total
$
51

 
$
(1,231
)
 
$
64

 
$
(1,065
)
 
 
 
 
 
 
 
 
Gains/(Losses) on derivative instruments:
 
 
 
 
 
 
 
Fair value hedges:
 
 
 
 
 
 
 
Foreign exchange contracts
$
(136
)
 
$
31

 
$
509

 
$
31

Interest rate contracts
671

 
(230
)
 
1,793

 
(1,178
)
Total
$
535

 
$
(199
)
 
$
2,302

 
$
(1,147
)
 
 
 
 
 
 
 
 
Gains/(Losses) related to hedged items:
 
 
 
 
 
 
 
Fair value hedges:
 
 
 
 
 
 
 
Marketable securities
$
136

 
$
(31
)
 
$
(508
)
 
$
(31
)
Fixed-rate debt
(671
)
 
230

 
(1,793
)
 
1,178

Total
$
(535
)
 
$
199

 
$
(2,301
)
 
$
1,147


Notional Amounts of Outstanding Derivative Instruments and Credit Risk Amounts Associated with Outstanding or Unsettled Derivative Instruments
The following table shows the notional amounts of the Company’s outstanding derivative instruments and credit risk amounts associated with outstanding or unsettled derivative instruments as of June 29, 2019 and September 29, 2018 (in millions):
 
June 29, 2019
 
September 29, 2018
 
Notional
Amount
 
Credit Risk
Amount
 
Notional
Amount
 
Credit Risk
Amount
Instruments designated as accounting hedges:
 
 
 
 
 
 
 
Foreign exchange contracts
$
55,067

 
$
1,179

 
$
65,368

 
$
1,015

Interest rate contracts
$
31,250

 
$
449

 
$
33,250

 
$

 
 
 
 
 
 
 
 
Instruments not designated as accounting hedges:
 
 
 
 
 
 
 
Foreign exchange contracts
$
54,744

 
$
184

 
$
63,062

 
$
259


v3.19.2
Condensed Consolidated Financial Statement Details (Tables)
9 Months Ended
Jun. 29, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]  
Property, Plant and Equipment, Net
Property, Plant and Equipment, Net
 
June 29,
2019
 
September 29,
2018
Land and buildings
$
16,560

 
$
16,216

Machinery, equipment and internal-use software
68,529

 
65,982

Leasehold improvements
8,895

 
8,205

Gross property, plant and equipment
93,984

 
90,403

Accumulated depreciation and amortization
(56,348
)
 
(49,099
)
Total property, plant and equipment, net
$
37,636

 
$
41,304


Other Non-Current Liabilities
Other Non-Current Liabilities
 
June 29,
2019
 
September 29,
2018
Long-term taxes payable
$
30,521

 
$
33,589

Other non-current liabilities
20,622

 
15,325

Total other non-current liabilities
$
51,143

 
$
48,914


Other Income/(Expense), Net
Other Income/(Expense), Net
The following table shows the detail of other income/(expense), net for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (in millions):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Interest and dividend income
$
1,190

 
$
1,418

 
$
3,855

 
$
4,375

Interest expense
(866
)
 
(846
)
 
(2,766
)
 
(2,372
)
Other income/(expense), net
43

 
100

 
216

 
(301
)
Total other income/(expense), net
$
367

 
$
672

 
$
1,305

 
$
1,702


v3.19.2
Debt (Tables)
9 Months Ended
Jun. 29, 2019
Debt Disclosure [Abstract]  
Summary of Cash Flows Associated with Issuance and Maturities of Commercial Paper The following table provides a summary of cash flows associated with the issuance and maturities of Commercial Paper for the nine months ended June 29, 2019 and June 30, 2018 (in millions):
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
Maturities 90 days or less:
 
 
 
Proceeds from/(Repayments of) commercial paper, net
$
(3,720
)
 
$
2,619

 
 
 
 
Maturities greater than 90 days:
 
 
 
Proceeds from commercial paper
12,977

 
9,782

Repayments of commercial paper
(11,283
)
 
(12,411
)
Proceeds from/(Repayments of) commercial paper, net
1,694

 
(2,629
)
 
 
 
 
Total repayments of commercial paper, net
$
(2,026
)
 
$
(10
)

Summary of Term Debt
The following table provides a summary of the Company’s term debt as of June 29, 2019 and September 29, 2018:
 
Maturities
(calendar year)
 
June 29, 2019
 
September 29, 2018
 
Amount
(in millions)
 
Effective
Interest Rate
 
Amount
(in millions)
 
Effective
Interest Rate
2013 debt issuance of $17.0 billion:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed-rate 2.400% – 3.850% notes
2023
2043
 
$
8,500

 
 
2.44%
3.91
%
 
$
8,500

 
 
2.44%
3.91
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2014 debt issuance of $12.0 billion:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Floating-rate notes
 
 
 

 
 
 
 
%
 
1,000

 
 
 
 
2.64
%
Fixed-rate 2.850% – 4.450% notes
2021
2044
 
6,500

 
 
3.12%
4.48
%
 
8,500

 
 
2.64%
4.48
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2015 debt issuances of $27.3 billion:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Floating-rate notes
2019
2020
 
1,488

 
 
1.87%
2.84
%
 
1,507

 
 
1.87%
2.64
%
Fixed-rate 0.350% – 4.375% notes
2019
2045
 
24,223

 
 
0.28%
4.51
%
 
24,410

 
 
0.28%
4.51
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2016 debt issuances of $24.9 billion:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Floating-rate notes
2019
2021
 
850

 
 
2.71%
3.65
%
 
1,350

 
 
2.48%
3.44
%
Fixed-rate 1.100% – 4.650% notes
2019
2046
 
22,022

 
 
1.13%
4.78
%
 
23,059

 
 
1.13%
4.78
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2017 debt issuances of $28.7 billion:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Floating-rate notes
2020
2022
 
2,750

 
 
2.61%
3.06
%
 
3,250

 
 
2.41%
2.84
%
Fixed-rate 0.875% – 4.300% notes
2019
2047
 
24,989

 
 
1.54%
4.30
%
 
25,617

 
 
1.54%
4.30
%
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
2018 debt issuance of $7.0 billion:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fixed-rate 1.800% – 3.750% notes
2019
2047
 
7,000

 
 
1.83%
3.80
%
 
7,000

 
 
1.83%
3.80
%
Total term debt
 
 
 
 
98,322

 
 
 
 
 
 
104,193

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Unamortized premium/(discount) and issuance costs, net
 
 
 
 
(194
)
 
 
 
 
 
 
(218
)
 
 
 
 
 
Hedge accounting fair value adjustments
 
 
 
 
337

 
 
 
 
 
 
(1,456
)
 
 
 
 
 
Less: Current portion of term debt
 
 
 
 
(13,529
)
 
 
 
 
 
 
(8,784
)
 
 
 
 
 
Total non-current portion of term debt
 
 
 
 
$
84,936

 
 
 
 
 
 
$
93,735

 
 
 
 
 
v3.19.2
Comprehensive Income (Tables)
9 Months Ended
Jun. 29, 2019
Equity [Abstract]  
Pre-tax Amounts Reclassified from AOCI into the Condensed Consolidated Statements of Operations
The following table shows the pre-tax amounts reclassified from AOCI into the Condensed Consolidated Statements of Operations, and the associated financial statement line item, for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (in millions):
 
 
 
 
Three Months Ended
 
Nine Months Ended
Comprehensive Income Components
 
Financial Statement Line Item
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Unrealized (gains)/losses on derivative instruments:
 
 
 
 
 
 
 
 
 
 
Foreign exchange contracts
 
Total net sales
 
$
(68
)
 
$
162

 
$
(102
)
 
$
433

 
 
Total cost of sales
 
13

 
206

 
(438
)
 
200

 
 
Other income/(expense), net
 
3

 
864

 
451

 
441

Interest rate contracts
 
Other income/(expense), net
 
2

 

 
5

 
(3
)
 
 
 
 
(50
)
 
1,232

 
(84
)
 
1,071

Unrealized (gains)/losses on marketable securities
 
Other income/(expense), net
 
(28
)
 
31

 
55

 
(49
)
Total amounts reclassified from AOCI
 
$
(78
)
 
$
1,263

 
$
(29
)
 
$
1,022


Changes in AOCI by Component
The following table shows the changes in AOCI by component for the nine months ended June 29, 2019 (in millions):
 
Cumulative Foreign
Currency Translation
 
Unrealized Gains/Losses
on Derivative Instruments
 
Unrealized Gains/Losses
on Marketable Securities
 
Total
Balances as of September 29, 2018
$
(1,055
)
 
$
810

 
$
(3,209
)
 
$
(3,454
)
Other comprehensive income/(loss) before reclassifications
(136
)
 
(678
)
 
4,340

 
3,526

Amounts reclassified from AOCI

 
(84
)
 
55

 
(29
)
Tax effect
13

 
163

 
(947
)
 
(771
)
Other comprehensive income/(loss)
(123
)
 
(599
)
 
3,448

 
2,726

Cumulative effect of change in accounting principle (1)

 

 
89

 
89

Balances as of June 29, 2019
$
(1,178
)
 
$
211

 
$
328

 
$
(639
)

(1)
Refer to Note 1, “Summary of Significant Accounting Policies” for more information on the Company’s adoption of ASU 2016-01 at the beginning of the first quarter of 2019.
v3.19.2
Benefit Plans (Tables)
9 Months Ended
Jun. 29, 2019
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Restricted Stock Unit Activity
A summary of the Company’s RSU activity and related information for the nine months ended June 29, 2019 is as follows:
 
Number of
RSUs
(in thousands)
 
Weighted-Average
Grant Date Fair
Value Per RSU
 
Aggregate
Fair Value
(in millions)
Balance as of September 29, 2018
92,155

 
$
134.60

 
 
RSUs granted
34,805

 
$
216.40

 
 
RSUs vested
(39,440
)
 
$
135.82

 
 
RSUs canceled
(4,478
)
 
$
161.14

 
 
Balance as of June 29, 2019
83,042

 
$
166.87

 
$
16,436


Summary of Share-Based Compensation Expense and the Related Income Tax Benefit
The following table shows share-based compensation expense and the related income tax benefit included in the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (in millions): 
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Share-based compensation expense
$
1,496

 
$
1,351

 
$
4,569

 
$
3,995

Income tax benefit related to share-based compensation expense
$
(502
)
 
$
(528
)
 
$
(1,583
)
 
$
(1,506
)

v3.19.2
Commitments and Contingencies (Tables)
9 Months Ended
Jun. 29, 2019
Commitments and Contingencies Disclosure [Abstract]  
Changes in Accrued Warranties and Related Costs
The following table shows changes in the Company’s accrued warranties and related costs for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (in millions):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Beginning accrued warranty and related costs
$
3,487

 
$
4,030

 
$
3,692

 
$
3,834

Cost of warranty claims
(912
)
 
(1,044
)
 
(2,823
)
 
(2,959
)
Accruals for product warranty
548

 
567

 
2,254

 
2,678

Ending accrued warranty and related costs
$
3,123

 
$
3,553

 
$
3,123

 
$
3,553


v3.19.2
Segment Information and Geographic Data (Tables)
9 Months Ended
Jun. 29, 2019
Segment Reporting [Abstract]  
Summary Information by Reportable Segment
The following table shows information by reportable segment for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 (in millions):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Americas:
 
 
 
 
 
 
 
Net sales
$
25,056

 
$
24,542

 
$
87,592

 
$
84,576

Operating income
$
7,442

 
$
7,496

 
$
26,329

 
$
26,580

 
 
 
 
 
 
 
 
Europe:
 
 
 
 
 
 
 
Net sales
$
11,925

 
$
12,138

 
$
45,342

 
$
47,038

Operating income
$
3,687

 
$
3,892

 
$
14,371

 
$
15,044

 
 
 
 
 
 
 
 
Greater China:
 
 
 
 
 
 
 
Net sales
$
9,157

 
$
9,551

 
$
32,544

 
$
40,531

Operating income
$
3,221

 
$
3,414

 
$
12,142

 
$
15,285

 
 
 
 
 
 
 
 
Japan:
 
 
 
 
 
 
 
Net sales
$
4,082

 
$
3,867

 
$
16,524

 
$
16,572

Operating income
$
1,795

 
$
1,765

 
$
7,199

 
$
7,193

 
 
 
 
 
 
 
 
Rest of Asia Pacific:
 
 
 
 
 
 
 
Net sales
$
3,589

 
$
3,167

 
$
14,132

 
$
13,978

Operating income
$
1,155

 
$
1,127

 
$
4,811

 
$
4,980


Reconciliation of Segment Operating Income to the Condensed Consolidated Statements of Operations
A reconciliation of the Company’s segment operating income to the Condensed Consolidated Statements of Operations for the three- and nine-month periods ended June 29, 2019 and June 30, 2018 is as follows (in millions):
 
Three Months Ended
 
Nine Months Ended
 
June 29,
2019
 
June 30,
2018
 
June 29,
2019
 
June 30,
2018
Segment operating income
$
17,300

 
$
17,694

 
$
64,852

 
$
69,082

Research and development expense
(4,257
)
 
(3,701
)
 
(12,107
)
 
(10,486
)
Other corporate expenses, net
(1,499
)
 
(1,381
)
 
(4,440
)
 
(3,816
)
Total operating income
$
11,544

 
$
12,612

 
$
48,305

 
$
54,780


v3.19.2
Summary of Significant Accounting Policies - Additional Information (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 29, 2019
Mar. 31, 2019
Sep. 30, 2018
Sep. 29, 2018
Apr. 01, 2018
Oct. 01, 2017
Significant Accounting Policies [Line Items]              
Reduction to other non-current assets upon adoption of ASU 2016-16 $ (33,634) $ (33,634)     $ (22,283)    
Potentially dilutive securities excluded from the computation of diluted earnings per share because their effect would have been antidilutive (in shares) 1.5 20.5          
Retained earnings              
Significant Accounting Policies [Line Items]              
Increase to retained earnings upon adoption of ASU 2016-16     $ 0 $ 2,501   $ 0 $ 278
Accounting Standards Update 2016-16              
Significant Accounting Policies [Line Items]              
Increase to net deferred tax assets upon adoption of ASU 2016-16       2,700      
Reduction to other non-current assets upon adoption of ASU 2016-16       128      
Accounting Standards Update 2016-16 | Retained earnings              
Significant Accounting Policies [Line Items]              
Increase to retained earnings upon adoption of ASU 2016-16       $ 2,600      
v3.19.2
Summary of Significant Accounting Policies - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Numerator:        
Net income $ 10,044 $ 11,519 $ 41,570 $ 45,406
Denominator:        
Weighted-average basic shares outstanding (in shares) 4,570,633 4,882,167 4,660,175 5,006,640
Effect of dilutive securities (in shares) 30,747 44,442 31,584 44,323
Weighted-average diluted shares (in shares) 4,601,380 4,926,609 4,691,759 5,050,963
Basic earnings per share (in dollars per share) $ 2.20 $ 2.36 $ 8.92 $ 9.07
Diluted earnings per share (in dollars per share) $ 2.18 $ 2.34 $ 8.86 $ 8.99
v3.19.2
Revenue Recognition - Additional Information (Details)
$ in Billions
Jun. 29, 2019
USD ($)
obligation
Sep. 29, 2018
USD ($)
Revenue from Contract with Customer [Abstract]    
Performance obligations in arrangements (up to) | obligation 3  
Total deferred revenue | $ $ 8.0 $ 8.8
v3.19.2
Revenue Recognition - Deferred Revenue, Expected Timing of Realization, Percentage (Details)
Jun. 29, 2019
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-06-30  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 68.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-06-28  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 25.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-06-27  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 6.00%
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-06-26  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, percentage 1.00%
v3.19.2
Revenue Recognition - Deferred Revenue, Expected Timing of Realization, Period (Details)
Jun. 29, 2019
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2019-06-30  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2020-06-28  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, period 1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2021-06-27  
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]  
Deferred revenue, expected timing of realization, period 1 year
v3.19.2
Revenue Recognition - Net Sales Disaggregated by Significant Products and Services (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Disaggregation of Revenue [Line Items]        
Net sales $ 53,809 $ 53,265 $ 196,134 $ 202,695
Revenue recognized that was included in deferred revenue at the beginning of the period 2,000 2,000 4,900 4,700
iPhone        
Disaggregation of Revenue [Line Items]        
Net sales 25,986 29,470 109,019 128,133
Mac        
Disaggregation of Revenue [Line Items]        
Net sales 5,820 5,258 18,749 17,858
iPad        
Disaggregation of Revenue [Line Items]        
Net sales 5,023 4,634 16,624 14,397
Wearables, Home and Accessories        
Disaggregation of Revenue [Line Items]        
Net sales 5,525 3,733 17,962 13,158
Services        
Disaggregation of Revenue [Line Items]        
Net sales $ 11,455 $ 10,170 $ 33,780 $ 29,149
v3.19.2
Financial Instruments - Cash, Cash Equivalents and Marketable Securities (Details) - USD ($)
$ in Millions
Jun. 29, 2019
Sep. 29, 2018
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost $ 210,179 $ 241,180
Unrealized Gains 892 209
Unrealized Losses (461) (4,289)
Fair Value 210,610 237,100
Cash and Cash Equivalents 50,530 25,913
Short-Term Marketable Securities 44,084 40,388
Long-Term Marketable Securities 115,996 170,799
Total cash, cash equivalents and marketable securities that were restricted from general use 19,500 20,300
Level 1    
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost 10,558 8,882
Unrealized Gains 0 0
Unrealized Losses 0 (116)
Fair Value 10,558 8,766
Cash and Cash Equivalents 10,558 8,083
Short-Term Marketable Securities 0 683
Long-Term Marketable Securities 0 0
Level 2    
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost 187,546 220,723
Unrealized Gains 892 209
Unrealized Losses (461) (4,173)
Fair Value 187,977 216,759
Cash and Cash Equivalents 27,897 6,255
Short-Term Marketable Securities 44,084 39,705
Long-Term Marketable Securities 115,996 170,799
Cash    
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost 12,075 11,575
Unrealized Gains 0 0
Unrealized Losses 0 0
Fair Value 12,075 11,575
Cash and Cash Equivalents 12,075 11,575
Short-Term Marketable Securities 0 0
Long-Term Marketable Securities 0 0
Money market funds | Level 1    
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost 10,558 8,083
Unrealized Gains 0 0
Unrealized Losses 0 0
Fair Value 10,558 8,083
Cash and Cash Equivalents 10,558 8,083
Short-Term Marketable Securities 0 0
Long-Term Marketable Securities 0 0
Mutual funds | Level 1    
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost   799
Unrealized Gains   0
Unrealized Losses   (116)
Fair Value   683
Cash and Cash Equivalents   0
Short-Term Marketable Securities   683
Long-Term Marketable Securities   0
U.S. Treasury securities | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost 37,307 47,296
Unrealized Gains 22 0
Unrealized Losses (102) (1,202)
Fair Value 37,227 46,094
Cash and Cash Equivalents 11,116 1,613
Short-Term Marketable Securities 8,436 7,606
Long-Term Marketable Securities 17,675 36,875
U.S. agency securities | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost 9,552 4,127
Unrealized Gains 1 0
Unrealized Losses (5) (48)
Fair Value 9,548 4,079
Cash and Cash Equivalents 7,711 1,732
Short-Term Marketable Securities 450 360
Long-Term Marketable Securities 1,387 1,987
Non-U.S. government securities | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost 20,569 21,601
Unrealized Gains 272 49
Unrealized Losses (63) (250)
Fair Value 20,778 21,400
Cash and Cash Equivalents 636 0
Short-Term Marketable Securities 3,467 3,355
Long-Term Marketable Securities 16,675 18,045
Certificates of deposit and time deposits | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost 4,838 3,074
Unrealized Gains 0 0
Unrealized Losses 0 0
Fair Value 4,838 3,074
Cash and Cash Equivalents 3,495 1,247
Short-Term Marketable Securities 1,273 1,330
Long-Term Marketable Securities 70 497
Commercial paper | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost 5,161 2,573
Unrealized Gains 0 0
Unrealized Losses 0 0
Fair Value 5,161 2,573
Cash and Cash Equivalents 4,930 1,663
Short-Term Marketable Securities 231 910
Long-Term Marketable Securities 0 0
Corporate debt securities | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost 93,896 123,001
Unrealized Gains 550 152
Unrealized Losses (173) (2,038)
Fair Value 94,273 121,115
Cash and Cash Equivalents 9 0
Short-Term Marketable Securities 29,027 25,162
Long-Term Marketable Securities 65,237 95,953
Municipal securities | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost 961 946
Unrealized Gains 9 0
Unrealized Losses (1) (12)
Fair Value 969 934
Cash and Cash Equivalents 0 0
Short-Term Marketable Securities 65 178
Long-Term Marketable Securities 904 756
Mortgage- and asset-backed securities | Level 2    
Debt Securities, Available-for-sale [Line Items]    
Adjusted Cost 15,262 18,105
Unrealized Gains 38 8
Unrealized Losses (117) (623)
Fair Value 15,183 17,490
Cash and Cash Equivalents 0 0
Short-Term Marketable Securities 1,135 804
Long-Term Marketable Securities $ 14,048 $ 16,686
v3.19.2
Financial Instruments - Additional Information (Details)
$ in Millions
3 Months Ended 9 Months Ended 12 Months Ended
Jun. 29, 2019
USD ($)
Vendor
Customer
Jun. 30, 2018
USD ($)
Jun. 29, 2019
USD ($)
Vendor
Customer
Jun. 30, 2018
USD ($)
Sep. 29, 2018
USD ($)
Vendor
Customer
Financial Instruments [Line Items]          
Non-marketable equity securities, carrying value $ 2,400   $ 2,400    
Hedged interest rate transactions, expected recognition period     8 years    
Fair value hedges, gains/(losses) excluded from effectiveness testing 171   $ 645    
Potential reduction to derivative assets resulting from rights of set-off under master netting arrangements 1,800   1,800   $ 2,100
Potential reduction to derivative liabilities resulting from rights of set-off under master netting arrangements 1,800   1,800   2,100
Net derivative assets/(liabilities) after potential reductions under master netting arrangements $ (14)   $ (14)   $ 138
Trade receivables | Credit concentration risk          
Financial Instruments [Line Items]          
Number of customers that individually represented 10% or more of total trade receivables | Customer 1   1   1
Trade receivables | Credit concentration risk | Customer one          
Financial Instruments [Line Items]          
Concentration risk, percentage     11.00%   10.00%
Trade receivables | Credit concentration risk | Cellular network carriers          
Financial Instruments [Line Items]          
Concentration risk, percentage     42.00%   59.00%
Non-trade receivables | Credit concentration risk          
Financial Instruments [Line Items]          
Number of vendors that individually represented 10% or more of total vendor non-trade receivables | Vendor 3   3   2
Non-trade receivables | Credit concentration risk | Vendor one          
Financial Instruments [Line Items]          
Concentration risk, percentage     57.00%   62.00%
Non-trade receivables | Credit concentration risk | Vendor two          
Financial Instruments [Line Items]          
Concentration risk, percentage     12.00%   12.00%
Non-trade receivables | Credit concentration risk | Vendor three          
Financial Instruments [Line Items]          
Concentration risk, percentage     12.00%    
Other current assets          
Financial Instruments [Line Items]          
Net cash collateral posted, derivative instruments         $ 1,000
Other current liabilities          
Financial Instruments [Line Items]          
Net cash collateral received, derivative instruments $ 603   $ 603    
Net sales          
Financial Instruments [Line Items]          
Non-designated derivatives, fair value adjustment gains/(losses) 58 $ 135 283 $ (7)  
Cost of sales          
Financial Instruments [Line Items]          
Non-designated derivatives, fair value adjustment gains/(losses) 40 151 108 (61)  
Other income/(expense), net          
Financial Instruments [Line Items]          
Non-designated derivatives, fair value adjustment gains/(losses) $ (34) $ 132 $ (58) $ (241)  
Hedges of foreign currency exposure associated with revenue and inventory purchases          
Financial Instruments [Line Items]          
Hedged foreign currency transactions, expected recognition period     12 months    
Hedges of foreign currency exposure associated with term debt and marketable securities          
Financial Instruments [Line Items]          
Hedged foreign currency transactions, expected recognition period     23 years    
Minimum          
Financial Instruments [Line Items]          
General maturities of long-term marketable securities     1 year    
Maximum          
Financial Instruments [Line Items]          
General maturities of long-term marketable securities     5 years    
v3.19.2
Financial Instruments - Marketable Securities in a Continuous Unrealized Loss Position (Details) - USD ($)
$ in Millions
Jun. 29, 2019
Sep. 29, 2018
Fair Value of Marketable Debt Securities    
Continuous Unrealized Losses, Less than 12 Months $ 11,853 $ 126,238
Continuous Unrealized Losses, 12 Months or Greater 71,984 60,599
Continuous Unrealized Losses, Total 83,837 186,837
Unrealized Losses    
Continuous Unrealized Losses, Less than 12 Months (44) (2,400)
Continuous Unrealized Losses, 12 Months or Greater (417) (1,889)
Continuous Unrealized Losses, Total $ (461) $ (4,289)
v3.19.2
Financial Instruments - Restricted Cash (Details) - USD ($)
$ in Millions
Jun. 29, 2019
Sep. 29, 2018
Jun. 30, 2018
Sep. 30, 2017
Supplemental Cash Flow Elements [Abstract]        
Cash and cash equivalents $ 50,530 $ 25,913    
Restricted cash included in other current assets 266      
Restricted cash included in other non-current assets 1,355      
Cash, cash equivalents and restricted cash $ 52,151 $ 25,913 $ 31,971 $ 20,289
v3.19.2
Financial Instruments - Derivative Instruments at Gross Fair Value (Details) - Level 2 - USD ($)
$ in Millions
Jun. 29, 2019
Sep. 29, 2018
Other current assets and other non-current assets | Foreign exchange contracts    
Derivative assets:    
Fair value of derivative assets $ 1,363 $ 1,274
Other current assets and other non-current assets | Interest rate contracts    
Derivative assets:    
Fair value of derivative assets 449  
Other current assets and other non-current assets | Derivatives designated as accounting hedges | Foreign exchange contracts    
Derivative assets:    
Fair value of derivative assets 1,179 1,015
Other current assets and other non-current assets | Derivatives designated as accounting hedges | Interest rate contracts    
Derivative assets:    
Fair value of derivative assets 449  
Other current assets and other non-current assets | Derivatives not designated as accounting hedges | Foreign exchange contracts    
Derivative assets:    
Fair value of derivative assets 184 259
Other current assets and other non-current assets | Derivatives not designated as accounting hedges | Interest rate contracts    
Derivative assets:    
Fair value of derivative assets 0  
Other current liabilities and other non-current liabilities | Foreign exchange contracts    
Derivative liabilities:    
Fair value of derivative liabilities 1,111 680
Other current liabilities and other non-current liabilities | Interest rate contracts    
Derivative liabilities:    
Fair value of derivative liabilities 112 1,456
Other current liabilities and other non-current liabilities | Derivatives designated as accounting hedges | Foreign exchange contracts    
Derivative liabilities:    
Fair value of derivative liabilities 860 543
Other current liabilities and other non-current liabilities | Derivatives designated as accounting hedges | Interest rate contracts    
Derivative liabilities:    
Fair value of derivative liabilities 112 1,456
Other current liabilities and other non-current liabilities | Derivatives not designated as accounting hedges | Foreign exchange contracts    
Derivative liabilities:    
Fair value of derivative liabilities 251 137
Other current liabilities and other non-current liabilities | Derivatives not designated as accounting hedges | Interest rate contracts    
Derivative liabilities:    
Fair value of derivative liabilities $ 0 $ 0
v3.19.2
Financial Instruments - Pre-Tax Gains and Losses of Derivative and Non-Derivative Instruments Designated as Hedges (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Cash flow hedges        
Derivative Instruments, Gain (Loss) [Line Items]        
Gains/(Losses) recognized in OCI – effective portion $ (147) $ 40 $ (689) $ 231
Gains/(Losses) reclassified from AOCI into net income – effective portion 51 (1,231) 64 (1,065)
Cash flow hedges | Foreign exchange contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Gains/(Losses) recognized in OCI – effective portion (147) 40 (689) 230
Gains/(Losses) reclassified from AOCI into net income – effective portion 53 (1,231) 69 (1,068)
Cash flow hedges | Interest rate contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Gains/(Losses) recognized in OCI – effective portion 0 0 0 1
Gains/(Losses) reclassified from AOCI into net income – effective portion (2) 0 (5) 3
Net investment hedges | Foreign currency debt        
Derivative Instruments, Gain (Loss) [Line Items]        
Gains/(Losses) recognized in OCI – effective portion (32) 13 (55) (18)
Fair value hedges        
Derivative Instruments, Gain (Loss) [Line Items]        
Gains/(Losses) on derivative instruments designated as fair value hedges 535 (199) 2,302 (1,147)
Gains/(Losses) related to hedged items in fair value hedges (535) 199 (2,301) 1,147
Fair value hedges | Foreign exchange contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Gains/(Losses) on derivative instruments designated as fair value hedges (136) 31 509 31
Gains/(Losses) related to hedged items in fair value hedges 136 (31) (508) (31)
Fair value hedges | Interest rate contracts        
Derivative Instruments, Gain (Loss) [Line Items]        
Gains/(Losses) on derivative instruments designated as fair value hedges 671 (230) 1,793 (1,178)
Gains/(Losses) related to hedged items in fair value hedges $ (671) $ 230 $ (1,793) $ 1,178
v3.19.2
Financial Instruments - Notional Amounts and Credit Risk Amounts Associated with Derivative Instruments (Details) - USD ($)
$ in Millions
Jun. 29, 2019
Sep. 29, 2018
Derivatives designated as accounting hedges | Foreign exchange contracts    
Derivative [Line Items]    
Derivative, notional amount $ 55,067 $ 65,368
Derivative, credit risk amount 1,179 1,015
Derivatives designated as accounting hedges | Interest rate contracts    
Derivative [Line Items]    
Derivative, notional amount 31,250 33,250
Derivative, credit risk amount 449 0
Derivatives not designated as accounting hedges | Foreign exchange contracts    
Derivative [Line Items]    
Derivative, notional amount 54,744 63,062
Derivative, credit risk amount $ 184 $ 259
v3.19.2
Condensed Consolidated Financial Statement Details - Property, Plant and Equipment, Net (Details) - USD ($)
$ in Millions
Jun. 29, 2019
Sep. 29, 2018
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment $ 93,984 $ 90,403
Accumulated depreciation and amortization (56,348) (49,099)
Total property, plant and equipment, net 37,636 41,304
Land and buildings    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment 16,560 16,216
Machinery, equipment and internal-use software    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment 68,529 65,982
Leasehold improvements    
Property, Plant and Equipment [Line Items]    
Gross property, plant and equipment $ 8,895 $ 8,205
v3.19.2
Condensed Consolidated Financial Statement Details - Other Non-Current Liabilities (Details) - USD ($)
$ in Millions
Jun. 29, 2019
Sep. 29, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]    
Long-term taxes payable $ 30,521 $ 33,589
Other non-current liabilities 20,622 15,325
Total other non-current liabilities $ 51,143 $ 48,914
v3.19.2
Condensed Consolidated Financial Statement Details - Other Income/(Expense), Net (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Organization, Consolidation and Presentation of Financial Statements [Abstract]        
Interest and dividend income $ 1,190 $ 1,418 $ 3,855 $ 4,375
Interest expense (866) (846) (2,766) (2,372)
Other income/(expense), net 43 100 216 (301)
Total other income/(expense), net $ 367 $ 672 $ 1,305 $ 1,702
v3.19.2
Income Taxes - Additional Information (Details)
$ in Millions, € in Billions
Aug. 30, 2016
EUR (€)
Subsidiary
Jun. 29, 2019
USD ($)
Income Tax Contingency [Line Items]    
Gross unrecognized tax benefits   $ 14,800
Gross unrecognized tax benefits that would impact effective tax rate, if recognized   8,100
Unrecognized tax benefits, gross interest and penalties accrued   1,300
Reasonably possible decrease in gross unrecognized tax benefits over next 12 months   $ 400
Unfavorable investigation outcome, EU State Aid rules    
Income Tax Contingency [Line Items]    
Number of subsidiaries impacted by European Commission tax ruling | Subsidiary 2  
Maximum potential loss related to European Commission tax ruling | € € 13.1  
Unfavorable investigation outcome, EU State Aid rules - interest component    
Income Tax Contingency [Line Items]    
Maximum potential loss related to European Commission tax ruling | € € 1.2  
v3.19.2
Debt - Additional Information (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Sep. 29, 2018
Debt Instrument [Line Items]          
Commercial paper $ 9,953   $ 9,953   $ 11,964
Commercial paper, general maturity period (less than)     9 months    
Commercial paper, weighted-average interest rate 2.49%   2.49%   2.18%
Floating- and fixed-rate notes, aggregate principal amount $ 98,322   $ 98,322   $ 104,193
Interest cost on term debt 790 $ 780 2,400 $ 2,200  
Level 2          
Debt Instrument [Line Items]          
Floating- and fixed-rate notes, aggregate fair value 102,500   102,500   103,200
Net investment hedges          
Debt Instrument [Line Items]          
Carrying value of debt designated as a net investment hedge $ 1,200   $ 1,200   $ 811
v3.19.2
Debt - Summary of Cash Flows Associated with Commercial Paper (Details) - USD ($)
$ in Millions
9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Maturities 90 days or less:    
Proceeds from/(Repayments of) commercial paper, net $ (3,720) $ 2,619
Maturities greater than 90 days:    
Proceeds from commercial paper 12,977 9,782
Repayments of commercial paper (11,283) (12,411)
Proceeds from/(Repayments of) commercial paper, net 1,694 (2,629)
Total repayments of commercial paper, net $ (2,026) $ (10)
v3.19.2
Debt - Summary of Term Debt (Details) - USD ($)
9 Months Ended
Jun. 29, 2019
Sep. 29, 2018
Debt Instrument [Line Items]    
Total term debt $ 98,322,000,000 $ 104,193,000,000
Unamortized premium/(discount) and issuance costs, net (194,000,000) (218,000,000)
Hedge accounting fair value adjustments 337,000,000 (1,456,000,000)
Less: Current portion of term debt (13,529,000,000) (8,784,000,000)
Total non-current portion of term debt 84,936,000,000 93,735,000,000
2013 debt issuance of $17.0 billion    
Debt Instrument [Line Items]    
Debt instrument, face amount 17,000,000,000  
2013 debt issuance of $17.0 billion | Fixed-rate 2.400% – 3.850% notes    
Debt Instrument [Line Items]    
Total term debt $ 8,500,000,000 $ 8,500,000,000
Debt instrument, maturity year (calendar), start 2023  
Debt instrument, maturity year (calendar), end 2043  
2013 debt issuance of $17.0 billion | Fixed-rate 2.400% – 3.850% notes | Minimum    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 2.40%  
Debt instrument, effective interest rate 2.44% 2.44%
2013 debt issuance of $17.0 billion | Fixed-rate 2.400% – 3.850% notes | Maximum    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 3.85%  
Debt instrument, effective interest rate 3.91% 3.91%
2014 debt issuance of $12.0 billion    
Debt Instrument [Line Items]    
Debt instrument, face amount $ 12,000,000,000  
2014 debt issuance of $12.0 billion | Floating-rate notes    
Debt Instrument [Line Items]    
Total term debt $ 0 $ 1,000,000,000
Debt instrument, effective interest rate 0.00% 2.64%
2014 debt issuance of $12.0 billion | Fixed-rate 2.850% – 4.450% notes    
Debt Instrument [Line Items]    
Total term debt $ 6,500,000,000 $ 8,500,000,000
Debt instrument, maturity year (calendar), start 2021  
Debt instrument, maturity year (calendar), end 2044  
2014 debt issuance of $12.0 billion | Fixed-rate 2.850% – 4.450% notes | Minimum    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 2.85%  
Debt instrument, effective interest rate 3.12% 2.64%
2014 debt issuance of $12.0 billion | Fixed-rate 2.850% – 4.450% notes | Maximum    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 4.45%  
Debt instrument, effective interest rate 4.48% 4.48%
2015 debt issuances of $27.3 billion    
Debt Instrument [Line Items]    
Debt instrument, face amount $ 27,300,000,000  
2015 debt issuances of $27.3 billion | Floating-rate notes    
Debt Instrument [Line Items]    
Total term debt $ 1,488,000,000 $ 1,507,000,000
Debt instrument, maturity year (calendar), start 2019  
Debt instrument, maturity year (calendar), end 2020  
2015 debt issuances of $27.3 billion | Floating-rate notes | Minimum    
Debt Instrument [Line Items]    
Debt instrument, effective interest rate 1.87% 1.87%
2015 debt issuances of $27.3 billion | Floating-rate notes | Maximum    
Debt Instrument [Line Items]    
Debt instrument, effective interest rate 2.84% 2.64%
2015 debt issuances of $27.3 billion | Fixed-rate 0.350% – 4.375% notes    
Debt Instrument [Line Items]    
Total term debt $ 24,223,000,000 $ 24,410,000,000
Debt instrument, maturity year (calendar), start 2019  
Debt instrument, maturity year (calendar), end 2045  
2015 debt issuances of $27.3 billion | Fixed-rate 0.350% – 4.375% notes | Minimum    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 0.35%  
Debt instrument, effective interest rate 0.28% 0.28%
2015 debt issuances of $27.3 billion | Fixed-rate 0.350% – 4.375% notes | Maximum    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 4.375%  
Debt instrument, effective interest rate 4.51% 4.51%
2016 debt issuances of $24.9 billion    
Debt Instrument [Line Items]    
Debt instrument, face amount $ 24,900,000,000  
2016 debt issuances of $24.9 billion | Floating-rate notes    
Debt Instrument [Line Items]    
Total term debt $ 850,000,000 $ 1,350,000,000
Debt instrument, maturity year (calendar), start 2019  
Debt instrument, maturity year (calendar), end 2021  
2016 debt issuances of $24.9 billion | Floating-rate notes | Minimum    
Debt Instrument [Line Items]    
Debt instrument, effective interest rate 2.71% 2.48%
2016 debt issuances of $24.9 billion | Floating-rate notes | Maximum    
Debt Instrument [Line Items]    
Debt instrument, effective interest rate 3.65% 3.44%
2016 debt issuances of $24.9 billion | Fixed-rate 1.100% – 4.650% notes    
Debt Instrument [Line Items]    
Total term debt $ 22,022,000,000 $ 23,059,000,000
Debt instrument, maturity year (calendar), start 2019  
Debt instrument, maturity year (calendar), end 2046  
2016 debt issuances of $24.9 billion | Fixed-rate 1.100% – 4.650% notes | Minimum    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 1.10%  
Debt instrument, effective interest rate 1.13% 1.13%
2016 debt issuances of $24.9 billion | Fixed-rate 1.100% – 4.650% notes | Maximum    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 4.65%  
Debt instrument, effective interest rate 4.78% 4.78%
2017 debt issuances of $28.7 billion    
Debt Instrument [Line Items]    
Debt instrument, face amount $ 28,700,000,000  
2017 debt issuances of $28.7 billion | Floating-rate notes    
Debt Instrument [Line Items]    
Total term debt $ 2,750,000,000 $ 3,250,000,000
Debt instrument, maturity year (calendar), start 2020  
Debt instrument, maturity year (calendar), end 2022  
2017 debt issuances of $28.7 billion | Floating-rate notes | Minimum    
Debt Instrument [Line Items]    
Debt instrument, effective interest rate 2.61% 2.41%
2017 debt issuances of $28.7 billion | Floating-rate notes | Maximum    
Debt Instrument [Line Items]    
Debt instrument, effective interest rate 3.06% 2.84%
2017 debt issuances of $28.7 billion | Fixed-rate 0.875% – 4.300% notes    
Debt Instrument [Line Items]    
Total term debt $ 24,989,000,000 $ 25,617,000,000
Debt instrument, maturity year (calendar), start 2019  
Debt instrument, maturity year (calendar), end 2047  
2017 debt issuances of $28.7 billion | Fixed-rate 0.875% – 4.300% notes | Minimum    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 0.875%  
Debt instrument, effective interest rate 1.54% 1.54%
2017 debt issuances of $28.7 billion | Fixed-rate 0.875% – 4.300% notes | Maximum    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 4.30%  
Debt instrument, effective interest rate 4.30% 4.30%
2018 debt issuance of $7.0 billion    
Debt Instrument [Line Items]    
Debt instrument, face amount $ 7,000,000,000  
2018 debt issuance of $7.0 billion | Fixed-rate 1.800% – 3.750% notes    
Debt Instrument [Line Items]    
Total term debt $ 7,000,000,000 $ 7,000,000,000
Debt instrument, maturity year (calendar), start 2019  
Debt instrument, maturity year (calendar), end 2047  
2018 debt issuance of $7.0 billion | Fixed-rate 1.800% – 3.750% notes | Minimum    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 1.80%  
Debt instrument, effective interest rate 1.83% 1.83%
2018 debt issuance of $7.0 billion | Fixed-rate 1.800% – 3.750% notes | Maximum    
Debt Instrument [Line Items]    
Debt instrument, stated interest rate 3.75%  
Debt instrument, effective interest rate 3.80% 3.80%
v3.19.2
Shareholders' Equity - Additional Information (Details) - USD ($)
shares in Millions
9 Months Ended
Jun. 29, 2019
Apr. 30, 2019
Apr. 29, 2019
Schedule of Stock Repurchase Program [Line Items]      
Maximum amount authorized for repurchase of common stock   $ 175,000,000,000 $ 100,000,000,000
Share repurchase program, amount utilized $ 78,200,000,000    
Number of shares repurchased (in shares) 252.6    
Amount of share repurchases $ 49,200,000,000    
February 2019 accelerated share repurchase arrangement      
Schedule of Stock Repurchase Program [Line Items]      
Number of shares repurchased (in shares) 55.1    
Amount of share repurchases, accelerated share repurchase arrangement $ 12,000,000,000.0    
v3.19.2
Comprehensive Income - Pre-tax Amounts Reclassified from AOCI into the Condensed Consolidated Statements of Operations (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Total cost of sales $ 33,582 $ 32,844 $ 122,055 $ 124,940
Other income/(expense), net (367) (672) (1,305) (1,702)
Total amounts reclassified from AOCI (11,911) (13,284) (49,610) (56,482)
Reclassifications out of AOCI        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Total amounts reclassified from AOCI (78) 1,263 (29) 1,022
Reclassifications out of AOCI | Unrealized (gains)/losses on derivative instruments        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Total amounts reclassified from AOCI (50) 1,232 (84) 1,071
Reclassifications out of AOCI | Unrealized (gains)/losses on derivative instruments | Foreign exchange contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Total net sales (68) 162 (102) 433
Total cost of sales 13 206 (438) 200
Other income/(expense), net 3 864 451 441
Reclassifications out of AOCI | Unrealized (gains)/losses on derivative instruments | Interest rate contracts        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Other income/(expense), net 2 0 5 (3)
Reclassifications out of AOCI | Unrealized (gains)/losses on marketable securities        
Reclassification Adjustment out of Accumulated Other Comprehensive Income [Line Items]        
Other income/(expense), net $ (28) $ 31 $ 55 $ (49)
v3.19.2
Comprehensive Income - Change in AOCI by Component (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Mar. 31, 2019
Sep. 30, 2018
Apr. 01, 2018
Oct. 01, 2017
AOCI Attributable to Parent, Net of Tax [Roll Forward]                
Beginning balances $ 105,860 $ 126,878 $ 107,147 $ 134,047        
Total other comprehensive income/(loss) 860 (47) 2,726 (2,683)        
Ending balances 96,456 114,949 96,456 114,949        
Total AOCI                
AOCI Attributable to Parent, Net of Tax [Roll Forward]                
Beginning balances (1,499) (3,064) (3,454) (150)        
Other comprehensive income/(loss) before reclassifications     3,526          
Amounts reclassified from AOCI     (29)          
Tax effect     (771)          
Total other comprehensive income/(loss) 860 (47) 2,726 (2,683)        
Cumulative effects of changes in accounting principles         $ 0 $ 89 $ 0 $ (278)
Ending balances (639) $ (3,111) (639) $ (3,111)        
Cumulative Foreign Currency Translation                
AOCI Attributable to Parent, Net of Tax [Roll Forward]                
Beginning balances     (1,055)          
Other comprehensive income/(loss) before reclassifications     (136)          
Amounts reclassified from AOCI     0          
Tax effect     13          
Total other comprehensive income/(loss)     (123)          
Ending balances (1,178)   (1,178)          
Unrealized Gains/Losses on Derivative Instruments                
AOCI Attributable to Parent, Net of Tax [Roll Forward]                
Beginning balances     810          
Other comprehensive income/(loss) before reclassifications     (678)          
Amounts reclassified from AOCI     (84)          
Tax effect     163          
Total other comprehensive income/(loss)     (599)          
Ending balances 211   211          
Unrealized Gains/Losses on Marketable Securities                
AOCI Attributable to Parent, Net of Tax [Roll Forward]                
Beginning balances     (3,209)          
Other comprehensive income/(loss) before reclassifications     4,340          
Amounts reclassified from AOCI     55          
Tax effect     (947)          
Total other comprehensive income/(loss)     3,448          
Ending balances $ 328   $ 328          
Accounting Standards Update 2016-01 | Total AOCI                
AOCI Attributable to Parent, Net of Tax [Roll Forward]                
Cumulative effects of changes in accounting principles           89    
Accounting Standards Update 2016-01 | Cumulative Foreign Currency Translation                
AOCI Attributable to Parent, Net of Tax [Roll Forward]                
Cumulative effects of changes in accounting principles           0    
Accounting Standards Update 2016-01 | Unrealized Gains/Losses on Derivative Instruments                
AOCI Attributable to Parent, Net of Tax [Roll Forward]                
Cumulative effects of changes in accounting principles           0    
Accounting Standards Update 2016-01 | Unrealized Gains/Losses on Marketable Securities                
AOCI Attributable to Parent, Net of Tax [Roll Forward]                
Cumulative effects of changes in accounting principles           $ 89    
v3.19.2
Benefit Plans - Additional Information (Details)
shares in Millions, $ in Billions
3 Months Ended 9 Months Ended
Jun. 29, 2019
USD ($)
shares
Jun. 30, 2018
USD ($)
Jun. 29, 2019
USD ($)
shares
Jun. 30, 2018
USD ($)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
Shares reserved for future issuance under stock plans (in shares) | shares 247.8   247.8  
Total unrecognized compensation cost related to RSUs and stock options $ 11.6   $ 11.6  
Total unrecognized compensation cost related to RSUs and stock options, weighted-average recognition period     2 years 7 months 6 days  
Restricted stock units        
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]        
RSUs granted, vesting period     4 years  
Number of shares of common stock issued per RSU upon vesting     1  
Factor by which each RSU granted reduces, and each RSU canceled or share withheld for taxes increases, the number of shares available for grant     2  
Fair value of RSUs as of the respective vesting dates $ 3.7 $ 3.3 $ 8.1 $ 6.9
v3.19.2
Benefit Plans - Restricted Stock Units Activity and Related Information (Details) - Restricted stock units
$ / shares in Units, shares in Thousands, $ in Millions
9 Months Ended
Jun. 29, 2019
USD ($)
$ / shares
shares
Number of Restricted Stock Units  
Beginning balance (in shares) | shares 92,155
RSUs granted (in shares) | shares 34,805
RSUs vested (in shares) | shares (39,440)
RSUs canceled (in shares) | shares (4,478)
Ending balance (in shares) | shares 83,042
Weighted-Average Grant Date Fair Value Per RSU  
Beginning balance (in dollars per share) | $ / shares $ 134.60
RSUs granted (in dollars per share) | $ / shares 216.40
RSUs vested (in dollars per share) | $ / shares 135.82
RSUs canceled (in dollars per share) | $ / shares 161.14
Ending balance (in dollars per share) | $ / shares $ 166.87
Aggregate Fair Value  
Aggregate fair value of RSUs | $ $ 16,436
v3.19.2
Benefit Plans - Summary of Share-Based Compensation Expense and the Related Income Tax Benefit (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]        
Share-based compensation expense $ 1,496 $ 1,351 $ 4,569 $ 3,995
Income tax benefit related to share-based compensation expense $ (502) $ (528) $ (1,583) $ (1,506)
v3.19.2
Commitments and Contingencies - Changes in Accrued Warranties and Related Costs (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Changes in Accrued Warranties and Related Costs [Roll Forward]        
Beginning accrued warranty and related costs $ 3,487 $ 4,030 $ 3,692 $ 3,834
Cost of warranty claims (912) (1,044) (2,823) (2,959)
Accruals for product warranty 548 567 2,254 2,678
Ending accrued warranty and related costs $ 3,123 $ 3,553 $ 3,123 $ 3,553
v3.19.2
Commitments and Contingencies - Additional Information (Details) - USD ($)
$ in Millions
9 Months Ended
Apr. 11, 2018
Sep. 30, 2016
Jun. 29, 2019
Commitments and Contingencies Disclosure [Line Items]      
Purchase commitments, period (up to)     150 days
Total future minimum lease payments under noncancelable operating leases     $ 11,100
Typical term of leases (not exceeding)     10 years
Unconditional purchase obligations     $ 8,100
VirnetX I | Pending litigation      
Commitments and Contingencies Disclosure [Line Items]      
Award from legal proceeding, due to other party   $ 302  
Award from legal proceeding, due to other party, revised amount, determined in subsequent proceedings   $ 440  
VirnetX II | Pending litigation      
Commitments and Contingencies Disclosure [Line Items]      
Award from legal proceeding, due to other party $ 503    
v3.19.2
Segment Information and Geographic Data - Summary Information by Reportable Segment (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Segment Reporting Information [Line Items]        
Net sales $ 53,809 $ 53,265 $ 196,134 $ 202,695
Operating income 11,544 12,612 48,305 54,780
Americas        
Segment Reporting Information [Line Items]        
Net sales 25,056 24,542 87,592 84,576
Operating income 7,442 7,496 26,329 26,580
Europe        
Segment Reporting Information [Line Items]        
Net sales 11,925 12,138 45,342 47,038
Operating income 3,687 3,892 14,371 15,044
Greater China        
Segment Reporting Information [Line Items]        
Net sales 9,157 9,551 32,544 40,531
Operating income 3,221 3,414 12,142 15,285
Japan        
Segment Reporting Information [Line Items]        
Net sales 4,082 3,867 16,524 16,572
Operating income 1,795 1,765 7,199 7,193
Rest of Asia Pacific        
Segment Reporting Information [Line Items]        
Net sales 3,589 3,167 14,132 13,978
Operating income $ 1,155 $ 1,127 $ 4,811 $ 4,980
v3.19.2
Segment Information and Geographic Data - Reconciliation of Segment Operating Income to Condensed Consolidated Statements of Operations (Details) - USD ($)
$ in Millions
3 Months Ended 9 Months Ended
Jun. 29, 2019
Jun. 30, 2018
Jun. 29, 2019
Jun. 30, 2018
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Operating income $ 11,544 $ 12,612 $ 48,305 $ 54,780
Research and development expense (4,257) (3,701) (12,107) (10,486)
Operating segments        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Operating income 17,300 17,694 64,852 69,082
Segment reconciling items        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Research and development expense (4,257) (3,701) (12,107) (10,486)
Corporate non-segment        
Segment Reporting, Reconciling Item for Operating Profit (Loss) from Segment to Consolidated [Line Items]        
Other corporate expenses, net $ (1,499) $ (1,381) $ (4,440) $ (3,816)